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Brcchcr and Waxier (194#) were ch« firme to difcover thac gold 
thioglucofo ((H'O) e«u««d obosity in mice. In 1955, Narthall et ml. 
found that kho hyp«rph«gia and obesity aaaociated with GTC resulted from 
a ventromedial hypothalas:ie (VKH) lesion. In the late sixties and 
seventies. Debona and his colleaguea pioneered the work that is now the 
foundation for (TTC leaion formation etiology, following the discovery 
by Mayer and Narahall (1956) that glucose is an essential part of (W# 
needed to produce <*TG necrosis* Debons demonstrated that CTG lesion 
formation is: insulin dependent (Debona et al., 1966; 1969; 1970); 
abolished by glucocorticoid administration (Debons et al., 1974b), 
serotonin dependent (Debons et al., 1979a), prevented by glucose analog 
(Likuski et al,, 1967), and glucose transport inhibitor (Debons et al., 
1974a) treatment; and highly specific for vm neural tissue (Debons et 
al., 1977; 1979b). Although Debons' laboratory showed that CTG is a 
specific neurotoxin for the VNB, speculation has continued over the 
specificity of (HQ lesion formation, Liebelt and Perry (1967) suggested 
that CTG caused VMH destruction solely by a breakdown in the 
vasculature. The resultant ischemia produced the VIW necrosis. Caffyn 
(1971; 1972a) allegedly substantiated this phenomenon by electron 
microscopic observations. Additional credence has been given to this 
idea by circumstantial speculation by Levine and Sowinski (1982; 1983) 
2 
and Nochlln and Levine (1982). 
In order to further elucidate the mechanism of CTC action in the 
VNR, and explore factors that may affect G7C lesion development in the 
VHH or VMM glucose oxidation, the ten studies comprising this 
dissertation were dom. 
Explanation of Thesis/Dissertation Format 
Each chapter in this dissertation stands alone as a manuscript 
prepared for submission to a scientific journal. Also, «very paper that 
comprises a chapter began as an original thought of the author. A 
General Introduction and Conclusions provide a continuity for the 
dissertation concept. Since each chapter possesses an extensive 
literature review, no general critical review of the literature is given 
to avoid redundancy. 
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SECTION 1. 
ALTERATIONS XN GLUCOSE METABOLISM 
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CHAPTER 1. SYSTEMIC PHLORIZIN PREVENTS COLD THIOCLUCOSE 
NECROSIS IN THE VENTROMEDIAL HYPOTHALAMUS 
Introduction 
Phlorizin (PHD it a well-known inhibitor of glucose transport in a 
variety of tissues (Lotspeich, I961t Silverman, 1981). Infusions of 
small amounts of PHL into the cerebral ventricles cause hyperphagia and 
body weight gain (Click and Mayer, 1968). However, intraperitoneal (IP) 
injections of PHL have no effect on eating (Click and Mayer. 1968). 
Click and Mayer (1968) suggested that PHL was affecting cerebral 
glucoreceptors involved with the control of food intake. Others 
(Crossauin, 1980; Stevenson, 1969) have suggested that the ventromedial 
hypothalamus (VMH) possesses these presumptive glucoreceptors, since 
this area has been implicated as a major center for food intake control. 
Gold thioglucose iCTC), when injected into mice IP, will cause an 
obesity syndrome (Brecher am* Waxier, 1949). This obesity development 
has been attributed to destruction of the VMH by (*TG (Marshall et al., 
1955). Debons et al. (1974a) demonstrated that unilateral 
intrahypothalamic injections of PBL into the VMH could abolish CTG 
lesion formation on the side of the brain receivii^ the PHL. These 
investigators also showed, by autoradiography, that cells in the VMH 
bound tritiated PHL (Debons et al., 1974a). These data supported the 
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idea that the VMM contained glucosensitive cells, which were involved 
with the control of food intake. 
Recently, Oebons and co-workers (1979b) have clearly demnstrated 
that GTG necrosis in the VMM is highly specific for the area, with 
neural components as the primary GIG target tissue. They have suggested 
that GTG could be used as a probe for hypothalamic function. In this 
study, we used the experimental method of Glick and Mayer (1968), 
involving parenteral injections of MIL, and increased the dose of PHL. 
Using GTG as a probe, changes in the VMH were observed by light 
microscopy. In addition, the effect of PHL on VMH glucose oxidation in 
vitro was assessed. 
Materials and Methods 
Cfl female mice, weighii^ 20-2) ga, were used in this study. The 
mice were maintained at 23^C, with a 12 hour lightt12 hour dark 
photoperiod and given Teklad Rat and Mouse Diet and tap water freely. 
PKL (900 mg/kg) was injected IP into mice 2 hours before GTG (300 
mg/kg) was administered IP, Since PWl is only slightly soluble in cold 
water, the suspension was heated to solubilise the PHL and injected. 
Dissolving PHL in hot water does not alter the chemical structure of the 
compound. Hot water injections followed by GTG served as controls. 
Animals were decapitated 24 hours after the GÏQ injection. The 
brains were removed from the skull and the VMM was dissected free as a 
cube of tissue and fixed overnight in 10% formalin. The tissues were 
embedded in 8Z agar and sectioned at 50 urn using a Smith and Farquhar 
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titau« ••etionor. CTG-inducod pathology of tha VMM was rapidly 
datarmifwd in ehaia aaetiona uting tha Panfiald modification of tha del 
Rio-Hortega ailver carbonate reaction for oligodendroglia (Hunaaon, 
1972) and light microacopy. For photographic purpoaea* aodw braina from 
each group were fixed in iouin'a fluid» dehydrated» embedded in 
paraffin* aectioned at 7 us, atained with hematoxylin and eoain» and 
photographed through a light nicroacope. 
The effect of PHL on VMR glucoae oxidation in vitro waa determined. 
Untreated animala were decapitated and the VMM waa diaaected free from 
the brain at the level of the median eminence aa a cube of tiaaue. Two 
VHR tiaaue cubea (capa) were placed in culture veaaela (2) ml Erlenmeyer 
flaaka with a gaa trap) containing 1.4? ml of medium, aaline, 15, 30, 45 
ug or 10.66 mg PttL in water and 7.) uCi of uniformly labeled D-
glucoae. The incubating medium waa aimilar to cerebral apinal fluid 
(Jonea et al., 197$), and aupplemented with 2.62 complete amino acid 
concentrate, 28.6% rat aerum, and 1.3% glutathione (200 mN). Final 
glucoae concentration waa 172 mg%. Other veaaela poaaeaaed no tiaaue 
and aerved aa controla for auto-oxidation of the D-glucoae. All 
veaaela were aealed with rubWr aeptuma and gaaaed for 30 seconda with a 
95% oxygen:5% carbon dioxide mixture. TW capa were allowed to incubate 
with PHL or saline in the medium 15 minutes at 37®C prior to the 
addition of D-glucose. The incubation was continued for 90 
minutes at 37'*G. The reaction was stopped and the carbon dioxide 
released by the addition of 9.0 N sulfuric acid (0.2 ml) to the medium. 
Hyamine (0.5 ml) was added to the gas trap to absorb the carbon 
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dioxide and incubated for an additional 60 minutes. The hyanlne was 
collected from each vessel, supplemented with 15 ml of a PPO and POPOP 
toluene scintillation cocktail, and emissions were counted with a 
Beckman 230 liquid scintillation counter. As a test for tissue 
viability* saline vessels with hypothalamic tissue were supplemented 
with 15 ul of 2.0 oM dinitrophenol in an aqueous solution and processed 
as described above. 
Atomic absorption spectrophotometery was used to determine the gold 
content in urine collected from mice injected with water or PRL and 
subsequently with CTC. Six mice were assigned to two groups. One group 
was injected with water and two hours later challenged with GIG. Group 
two was administered PHL and given GTG two hours after the PHL 
Injection. Urine was collected for four hours following GTG 
administration. The quantity of urine collected from each animal was 
approximately 5.0 ml. A Perkln-Elmer 503 Atcmic Absorption 
Spectrophotometer with a 2100 Controller and a IKA-74 graphite cell was 
used to measure the total gold content of each urine sample. The 
saoules were frozen, lyophyllzed, resuspended in 1.0 ml water and the 
eleoMntal gold extracted with methyl lao-butyl ketone, usii^ the 
procedures outlined by Perkin-Elmer. A standard curve was obtained 
using various concentrations of gold chloride. The samples were 
processed with the following parameters: argon gas flow—15.0 
cc/mimite: wavelength—243.3 nm; drying temperature—120*^0 for 50 
seconds, charring temperature—SOO^C for 50 seconds, atomizing 
temperature—'2200°C for 5 seconds, and injection volume—5 ul. 
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A on« way analysis of variance and Dunnote's test, and t-test were 
used to determine statistical significance. 
Results 
Control animals injected with hot water and subsequently with GTC 
displayed typical GtG lesions in the VMM (Figure 1A>. Mice treated with 
PHL and GTC showed complete inhibition of GTG necrosis in the 
hypothalamus (figure IB* Table I). These brain sections were 
indistinguishable fr<mi untreated mouse brains. 
Analysis of variance indicated that differences were present among 
the in vitro P8L treatments, F(4,16)»14.27. PHL did not inhibit glucose 
oxidation in the VNH at low concentrations (Figure 2). In fact, the 
lowest supplement of PHL to the medium caused glucose oxidation to 
increase significantly (p<0.00l). This phenomenon will be discussed 
below. At a hig^ coiwentration, PHL depressed glucose oxidation by iOZ 
(Figure 2). This inhibition of glucose oxidation by PHL was highly 
significant (p<0.(M)l). 
Determination of glucose oxidation in normal and CMG-kreated tissue 
cubes indicated that 75% of each tissue cube contained neuronal elements 
vulnerable to GTC (Table II). Histological examination confirmed this 
observation. In addition, injections of necrotizing GTG doses (300-
800 mg/kg) generally produce lesions of equivalent size in mice 
(personal observation). 
The presence of dinitrophenol, an uncoupler of oxidative 
phosphorylation, in the incubation medium caused glucose oxidation to 
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increase greatly (10.8 x 10'^ mole# glucose oxidized/mg tissue/hour), a 
process analogous to the Pasteur effect. This response to dinitrophenol 
poisoning indicates that tissue viability waa not impaired during 
incubation. 
Although PHL can produce diuresis (Lotspeich, 1961 ; Silverman, 
1981), GTG excretion apparently wa# not enhanced. Control animal# given 
water aW GTG excreted 187+32 (mean+SEH) ug of gold/pi body weight in 
the urine, over the four hour interval following the GTG injection. The 
PRL and GTG treated animal# excreted #uch amall amount# of gold during 
the #ame time period, that the element wa# eaaentially undetectable 
using our machine setting# and the Perkin-Elmer protocol. Only one of 
the three PHL and GTG sample# had any measureable gold content, 
1.3 ug/gm body weight. Unexpectedly the PHL treated mice excreted 
significantly les# ^Id in the urine than the control#, p<0.001. 
Di#cu#eion 
Click and Mayer (1968) have reported that intraventricular 
infusion* of PHL produce s cusfcained hyperphagia and body weight gain. 
This over-eating phenomenon is probably cau#ed by the inhibition of 
glucose utilisation in the hypothalamus by PHt. Consistent with this 
idea, Oebon# and colleagues (1974a) have illustrated, by 
autoradiographic techniques, that PHL can bind to specific cells in the 
VMH. This area of binding i# also the site of initial (^C-induced 
necrosis which leads to hyperphagia. In conjunction with this 
experiment, Debon# et al. (1974a) were able to inhibit GTG lesion 
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formation in the VNH by intrahypothalanic PHL injections. Although the 
method of injection used by Debons* group has been questioned (Brown and 
Viles, 1980), the data presented (Debons et al., 1974a) are convincing. 
In this study, we have shown that an IP injection of PHL prevented CTC 
necrosis in the VNH (Figure 1). Also, it has been demonstrated that PHL 
can be a stroi% inhibitor of glucose oxidation in the VMH in vitro 
(Figure 2). 
Although the in vitro VHH glucose oxidation experiments clearly 
demonstrated that PHL, in high concentrations, can inhibit glucose 
utilisation, the significant increase of glucose oxidation by VMM tissue 
at the lowest concentration of PHL utilized, presented an enigma, 
Lotspeich (1961) found that PHL inhibition of kidney glucose transport 
could be reversed by the addition of adenine nucleotides. This result 
suggested that PHL may be inhibiting glucose reabsorption by affecting 
the ATP sensitive, Na* dependent, glucose transport system. Hence, our 
apparent increase in VNH glucose utilization at a low PHL concentration 
is analogous to the dinitrophenol effect mentioned earlier. Thus, this 
low dose PHL phenomenon can be explained by the Pasteur effect. 
Click and Mayer (1966) injected PHL parenterally; however, 
hyperphagia did not ensue as seen with intraventricular PHL infusions. 
In hij^ concentrations, PHL is able to inhibit glucose oxidation in VMH 
tissue in vitro, while at a low concentration PHL significantly enhanced 
glucose oxidation. These results suggest the dosage Click and Mayer 
used (1,0 mM) may have been too small to cause hypothalamic hyperphagia. 
Indeed, the amount of PHL injected IP apparently is important for 
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altering hypothalamic function. A large toxic dome of PHL completely 
suppresaed GTC necrosis in the VMM at the light nicroscopic level. 
It has been postulated that glucoreceptor cells exist in the VMM, 
which function in ttw regulation of feedir^ behavior (Mayer, 1953). 
Since intrahypothalamic PHL implants appear to inhibit CTC necrosis 
(Debons et al., 1974a), a glucose transport mechanism may be involved 
with (flC lesion formation in the VNR. In other words, CÎC may be 
prevented from interacting with the neural components possessing 
glucoreceptors. PHL is probably competing with CTC for the receptor 
sites sensitive to glucose in the VMM, 
PHL may have an impact upon the blood-brain barrier (BBB), If PHL 
does block transport at the BBB, this phenomenon could account for the 
lack of («TC-induced necrosis in the V|% aa a result of PHL 
administration. When 2-deo»yglueose was used as a reference, PHL did 
not effect hexose transport across the BBB (Dean# and Segal, 1979). 
This lack of inhibition of sugar transport at the BBB indicates that PHL 
probably does not affect (TTC transport into the brain. Thus, the PHL 
blockage of CtG necrosis probably occurs in the vm. 
Finally, PHL is known to produce glucosuria by preventing 
reabsorption of glucose from the renal tubules (Lotspeich, 1961). 
Prevention of (ÎTC lesion formation in the VMH of mice treated with PHL 
could conceivably be due to a rapid renal excretion of (yrC produced by 
PHL. However, the specific effects of PHL on the kidney must be 
considered. PHL has its greatest effect on renal glucose excretion 
during the initial 120 minutes after injection (Braun et al., 1957). 
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Subs«qu«nt time intorvals show a decrease in the glucose excretion rate 
(Braun et al.» 1957). In addition, kidneys perfused with PHL in 
normoglycemic dogs, show only a 40% loss of glucose due to malabsorption 
(Lotspeich, 1961). In the present study, we injected mice with GTG two 
hours after PHL administration to avoid a significant loss of GTG in the 
urine, assuming the reabsorption of GTG in the kidney is affeted by PHL. 
Debona et al. (1968) have demonstrated that continuously high blood 
levels of GTG are not necessary for lesion formation. In fact the 
amount of GTG in whole blood begins to decline 10 mimttes after 
administration. Since a high, long-lasting GTG blood concentration i* 
not necessary for VMM lesion formation CDebons et al., 1968), and 
precautions were taken to avoid excessive renal GTG excretion due to 
PHL, it is predicted that sufficient amounts of GIG were present in the 
blood and brain of animals treated with PHL and GTG to cause VMH 
necrosis. In an effort to demonstrate definitely that PHL did not cause 
excessive excretion of GTG in the urine, and thus prevent VNH lesion 
formation, we measured the total amount of gold in a four hour post GfC 
urine sample, from mice treated with and without PHL. Hice injected 
with water and GTG excreted significantly larger amounts of gold in the 
urine coa^ared to PHL and GTG treated mice (p<0,Wl; see Results). This 
result clearly demonstrates that PHL did not abolish GTC lesion 
formation in the VHB by increasing the excretion rate of GTG over 
controls. Furthermore, since no VHH lesions developed in PHL treated, 
GTC challenged mice, PHL apparently affected the VNH directly, thereby 
preventing any GTG induced damage from occurring in the area. 
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Tha evidence reported in this study indicate the PHL dosage used by 
Click and Mayer (1968) was in fact too small to affect food intake, when 
given IP. The large IP PHL injection used in this investigation 
inhibited GTG lesion formation in the VMM. Large doses of PHL also 
inhibited VMM glucose oxidation in vitro. These results substantiate 
the possible involvement of a glucoreceptor and/or glucose transport 
mechanism, in relation to VMM function determ^ined by (*7C vulnerability. 
Moreover, our data support the concept of a glucostatic modulation of 
feeding behavior (Mayer, 1933). 
figur* 1. Coronal Mcelons of mourn# brain, ahowing th« VHH at th# laval 
of th# median oniin«nc«, 24 hour# aftar a GIG injaetion. A. 
Rot water givan XP initially, followed by CTG (300 sg/kg). 
B. PHL (900 ng/kg) given XP initially, followed by CTG 
(300 og/kg). Bare represent 0.1 mm, (90X) 

figure 2. Th« «ffcct of vcriou* concentration* of PRL on Vtffi glueote 
oxidation in vitro. The barm indicated the mean SEM. 
• piO.OOl 
mom ido-* oiucosE oxiiN»/»t nssuf/Hout 
S b S o o 
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TABLE 1. Effect of phlorizin on GTC^ lemion formation in the VMM 
Treatment n % Incidence of 
Necrosis 
Phlorizin (900 5 0 
Water 9 100 
® 300 mg/kg. 
19 
TABLE 11. Effect of GTC Leslona on Clucosa Oxidation in vitro 
Molaa X 10'^ glucose 
Treatment n oxidised/gn tissue/hr 
(%+SEM) 
Control 8 3.31 * 0,20 
GTC (300 ngAg) 8 0.84 + 0.10* 
* Significantly different fro# control, p<0.001, 
20 
CHAPTER 2. GLUCOSE ANALOG EFFECTS ON GLUCOSE OXIDATION 
IN THE VENTROMEDIAL HYPOTHALAMUS 
Introduction 
Glueof« analog# have b«cn used «xCenaively in the study of glucose 
transport and glucoss-Mdiatad responses in vitro. Glucosamine (GLA), 
mannoheptulose (MAN), and Z-deoxyglucose (20C) all block insulin release 
from pancreatic islets in response to a glucose stimilus (Coore and 
Randle, 1964 a and b; Montague and Taylor, 1968). In addition, 
pancreatic glucose utilisation is impaired 2DC, MAN, and GLA (Wicks 
et al., 1955 a and b; 1956; Ashcroft et al., 1970; Sols and Crane, 1954; 
Ishibashi et al., 1981), which suggested a competitive inhibition of 
glucose binding to pancreatic glucoreceptors and possible competitive 
inhibition of glucose utilization. In answer to these possibilities, 
2C6 and MAN inhibit glucose utilization at transport and phosphorylation 
levels in glucose metabolism (Ullrey et al., 1982; Coore and Randle, 
1964 a and b). Hwever, GLA can decrease glucose oxidation by 
inhibiting transport as well as phosphorylation and subsequent glucose 
metabolism (Ashcroft et al., 1970; Ullrey et al., 1982). 
Cold thioglucose (CÎG) is a substrate-specific neurotoxin for a 
small neuronal cell population in the ventromedial hypothalamus (VHH). 
Destruction of these cells with GTG leads to hyperphagia and eventually 
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obesity (O«bons et al., 1977). However, in pancreatic tissue, GTG 
causes an enhancement of insulin secretion with or without glucose 
present in vitro, with no apparent cell toxicity (Caterson and Taylor, 
1979; Rahn et al,, 1980). This observation suggests that differences 
may exist between the brain and pancreas with respect to glucose 
metabolism. To investigate this possibility, we tested the effect of 
NAN, 20C, CLA and GTG on VNH glucose oxidation in vitro. 
Materials and Methods 
Female CFl mice, weighing between 20-25 grams, were housed at 23^C 
with a 12-hour light;12-hour dark photoperiod, fed Teklad Rat and Mouse 
Diet and given tap water freely. Animals were decapitated and the V)Oi 
was dissected free fro# the brain at the level of the median eminence a# 
a cube of tissue weighing approximately 3.0 mg. Histological 
observations and the monitoring of glucose oxidation in normal and GtG-
lesioned tissue cubes indicated that 75% of each VMM tissue cube 
contained neuronal elements vulnerable to GTG (Brown and Viles, 1980; 
1982), Two tissue cubes (caps) were placed in culture vessels (25 ml 
Erlenmyer flasks with a gas trap) containing 1.47 ml of medium and 7.5 
uCi of uniformly labeled D-glucose. The incubatii^ medium was 
similar to cerebral spinal fluid, prepared according to Jones et al. 
(1975). The medium contained 9.6 mM (2.58 b^) glucose, and was 
supplemented (volume to volume) with 2.6% complete amino acid 
concentrate, 28.6% rat serum, and 1.3% glutathione (200 mM). The 
vessels were supplemented with 2.58 mg, 5.16 mg or 7.74 mg (1, 2 or 3 
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tidws tha quantity of glucoso In the medium, respectively) of 2DC, MAN, 
or GLA, or an equal volume of saline. GTC supplements were 3 or 6 time* 
the amount of glucose in the medium. Millimolar concentrations for the 
various compounds are given in the figures. Other vessels possessed no 
tissue but contained 2DC, NAN, GLA, GTC, or saline and served as 
controls for auto-oxidation of the D-glucose. The vessels were 
sealed with rubber septums and gassed with a 952 oxygen;)* carbon 
dioxide mixture. The VMM caps were allowed to incubate with 2DC, MAN, 
GLA, GTC, or saline in the medium for % minutes at 37*C before the 
D-glucose was added. After the addition of [**C] D-glucose, the 
incubation was continued for 90 minute*. The reaction was stopped and 
the COg released by the addition of 9.0 N W^SO^ (0.2 to the 
medium. Myamdne (Sigma) (0.5 ml) was added to the gas trap to absorb 
the (XXg and incubated for an additional 60 mimites. The hyamiw 
was collected from each vessel and counted by liquid scintillation 
spectrometry with a Beckman 250 liquid scintillation counter. As a test 
for tissue viability, saline vessels with hypothalamic tissue were 
supplemented with 15 ul of 2.0 mM dinitriphenol (M$P) (Fisher) in an 
aqueous solution and processed as described above. Furthermore, as 
expected, varying the amount of D-glucose in the incubation system 
altered glucose oxidation linearly, as a function of labeled glucose 
activity. Analysis of variance with Dunnett's test was used to analyze 




NAN (Flguro 1} and CTC (Figure 2) had no effect on glucose 
oxidation in the VHH. No inhibition of glucose oxidation was observed 
at aIV concentration of NAN (1, 2 or 3 times the amount of glucose in 
the medium) or GTG (3 or 6 times the amount of glucose in the meduim). 
CLA caused a nonsignificant decrease in glucose oxidation at a quantity 
3 times that of glucose (Figure 3). The 2% amounts of CLA had little or 
no effect on CO^ production fron glucose in the VNH. However* CLA 
present in the medium at a quantity equal to that of glucose caused a 
significant enhancement of glucose oxidation (Figure 3). 
The 20G did have an inhibitory effect on VNH COj production 
from glucose. Although glucose oxidation was depressed with 20C levels 
at 1 or 2 times the amount of glucose in the medium, significant 
inhibition of glucose oxidation was not observed until the 20G 
concentration ^  weight was 3 times that of glucose (Figure 4), As the 
200 coiwentration was increased and the glucose concentration remained 
constant, the inhibition of glucose oxidation in the VIM also increased 
(Table I). However, the inhibition was not a 1:1 relationship; an 
amwnt of 20G three times greater than glucose was needed in the medium 
to inhibit glucose oxidation 50%. The was determined to be 11.96 » 
10"^ H with an inhibition maximum (I ) of lOOZ, as determined by a 
max 
double reciprocal plot (Figure 5), However, a Niehaelis-Nenten plot for 
kinetic analysis revealed an atypical curve (Figure 5, inset). 
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Discussion 
Employing 20C, NAN, and GLA, three inhibitors of glucose 
utilization in the pancreas, it was found that quantities of 2DG at 
least three times greater than glucose were necessary to achieve any 
significant reduction in glucose oxidation in the VMH. GLA did inhibit 
glucose utilization at a quantity three times that of glucose present, 
but this depression was not significant. HAN had no effect. Also, the 
neurotoxin GTG had iw effect on VMH glucose oxidation in vitro. Since 
2DC and MAN should block the glycolytic pathway by competitively 
inhibiting phosphoglucose isomerase (5.3.1.9) (Ashcroft et al., 1970), 
these sugars would be expected to inhibit glucose oxidation at much 
lower concentrations. In fact, the apparent of 11.96 x 10'^ N for 
20C is BMch higher than the physiological range and more closely 
resembles a pharmacological effect. The atypical Michaelis-Menten plot 
is also suggestive of a non-physiological effect (Figure 5, inset). 
MAN has differential effects on the high and low hexokinase 
in pancreatic islets (Zawalich et al., 1978; Ishibashi et al., 1981). 
The high K hexokinase is blocked by MAN but the low K hexokinase is 
m m 
unaffected. This phenomenon may account for the lack of MAN inhibition 
on VMH glucose oxidation. GLA is a transport and metabolic blocker of 
glucose utilization. However, no significant inhibitory effect on VMH 
glucose oxidation was found, although a trend towards a significant 
decrease in glucose utilization was discerned. No conclusion concerning 
the metabolic level(s) of GLA inhibition of VMH glucose oxidation can be 
made from our data. Alternately, since an in vitro incubation system 
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warn used with an exceea of glucoss and glucose analogs, Che Crabtree 
effect night be responsible for the apparent inhibition of glucose 
oxidation, particularly at the high concentrations utilised. 
Interestingly, GTC had no effect on VNH glucose oxidation. This 
neurotoxin produces necrosis in the mouse VMM within 24 hours after 
injection (Oebons et al., 1977), albeit no neural damage is seen until 4 
hours after GIC injection (personal observation). The short incubation 
time used in these studies could account for the absence of any GTC 
effect on glucose oxidation in the VMH. Furthermore, even shorter 
pancreatic islet incubation times were used in the studies illustrating 
a GTC potentiation of insulin secretion (Caterson and Taylor, 1979; Wahn 
et al., 1980). The possibility of damage to the cells of the VMM during 
dissection and incubation cannot be dismissed. However, the uncoupling 
of oxidative phosphorylation by OHP produces a threefold increase in 
glucose oxidation during incubation (Brown and Viles, 1980; 1982), 
suggesting that potential damage by the experimental procedures was a 
minimal factor in impairing tissue viability. Moreover, Coore and 
Randle (1964, a and b) point out that the inhibitors NAN, CLA, an4 2DC 
have no cytotoxicity in the pancreas. This may not be true for Vlfil 
tissue, however, 2DC pretreatment can prevent CTCr-induced lesion 
formation in the VIW (Likuski et al., 1967). 
None of the glucose analogs tested in these experiments exhibited 
significant inhibition of glucose oxidation by the VIU at approximate 
equimolar concentrations. This result suggests that these analogs were 
not effective in competing with glucose for the glucose utilization 
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pathways in the VNH of which glucose oxidation is one. Possibly high 
affinity binding is characteristic of glucoreceptors in the VNH, 
lessening competitive inhibition by the analogs* this same effect may be 
operating at the level of the transport or enzyme systems. 
Figure 1. Tlw effect of various concentrations of MAN on VMM glucose 
oxidation in vitro. The bars indicate the mesfwSEM. IX» 2X 
and 3% represent the amount of HAN in the medium expressed as 
multiples of the amount of glucose in the medium 
MOliS K10-* GUICOSi OXiOIZa>/»0 nSSIIE/HOUi 
Figure 2. The effect of verioue concentrationa of OTC on VMM glucoae 
oxidation in vitro. The bar# indicate t)w neainSEM. 3X and 
6X represent the amount of GTG in the medium expressed as 
multiples of the amount of glucose in the medium 
0 
Figure 3. Ttw effect of variou# concentrations of GLA on VMi glucoce 
oxidation in vitro. The bars indicate the near^SEN. IX, 2X 
and 3X represent the amount of GLA in the medium expressed as 
multiples of the amount of glucose in the medium. * p<0.01 
mom » 10-* OUICOSE OXWNZBD/m# mSUE/HOUl 
s s s J I I 
Figure 4. T)ie effect of vsriouc concentration# of 2DG on VM# glucoee 
oxidation in vitro. The bar# indicate the meatrHSIH. IX, 2X 
and 3X represent the amount of 2DC in the medium expre##ed as 
multiple# of the amount of glucose in the medium. * p<O.OOS 
MCNUU % 10-* GLUCOSE OXMNZED/mg IISSUE/HOUi 
S S S 
J I I 
figure 5. A double reciprocal plot of the 2DC inhibition kinetic data. 
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CHAPTER 3. GLUCOSE OXIDATION IN THE VENTROMEDIAL HYPOTHALAMUS 
IS NOT AFFECTED BY INSULIN OR OUABAIN BUT 
DEPRESSED BY ALLOXAN TREATMENT 
Introduction 
Insulin enhance# the uptake and utilization of glucose in a variety 
of tissues. A notable exception has been the brain; insulin appears to 
have no effect on the central nervous system (CMS). Crodsky and Frohnan 
(1966) showed that insulin does not cross the blood-brain barrier. 
Glucose uptake and utilization in the brain occurs in the absence of 
insulin (Frohnan, 1969), apparently by a diffusion process. However, 
Frasannan (1972) reported the presence of an insulin effect on glucose 
uptake in the brain. Moreover, an insulin-sensitive glucoregulator 
cheinoreceptor has been illustrated to exist in the CMS (Szabo and Szabo, 
1972s Chen et al., 1975). Havrankova et al. (1978a) have demonstrated 
insulin receptors are plentiful in the brain. In addition, the 
hypothalamic imclei contain the highest levels of insulin compared to 
other parts of the CNS (Havrankova et al., 1978b). 
The ventromedial hypothalamus (VMB) has long been reputed to be 
involved with the control of food intake and satiety (Debons et al., 
1977). Debons et al. (1969; 1970) have demonstrated that insulin has a 
direct effect on gold thioglucose ((^TG) responsiveness in the VMH. The 
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VNR can be dastroyad with a singla intraparitonaal injection of CTG, 
causing hyperphagia and eventually obesity (Marshall et al., 1955). The 
characteristic lesions induced by CTC are not seen in alloxan-diabetic 
or anti-insulin serum diabetic animals. Intrahypothalamdc insulin 
injections into the of diabetic animals causes a return of the VMM 
susceptibility to CTC necrosis. This evidence indicates that the VMM 
has a sensitivity to insulin, and requires the presence of insulin for 
normal function. The pathway by which insulin reaches the VHR is 
unknown, however, there is a strong possibility that this may occur via 
the cerebral spinal fluid (Margolis and Altssuler, 1967). 
Clucose transport can be coupled with the sodium-potassium pump 
mechanism as a cotransport phenomenon (Stryer, 1975). The brain 
possesses a heterogeneous, ATP-dependene sodium-potassium transport 
system (Mark* and Seeds, 1979), It is conceivable that glucose 
transport in the brain and possibly satiety mediation may b« coupled 
with a sodium-potassitm pump mechanism. Ouabain, a sodium-potassium 
pump ATFase inhibitor (Schwarts et al., 1972; Mark* and Seed*, 1979), 
could be used to elucidate the involvement, if any, of the «odium-
potas*ium pua^ with glucose utilization in the VMM. 
To further *tudy the effects of ouabain or insulin on the VMS, an 
in vitro system for incubating hypothalamic tissue from mice was 
employed. 
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Materials and Methods 
Female CPl mice, weighing between 20-23 gn, were used in this 
study. The ndce were maintained at 23**C with a 12 hour light:12 hour 
dark photoperiod, fed Teklad Rat and Mouse Diet and given tap water 
freely. 
Normal animals were utilized for the ouabain investigations, while 
diabetic animals were used for the insulin experiments. Diabetes 
mellitus was induced by a single 100 mg/kg intravenous injection of 2.0% 
aqueoua alloxan. On the third day post injection, the animala were 
teated for glucosuria using Clinistix, as an indicator of the diabetic 
condition, and used for experimentation. 
Animals were decapitated and the VMM waa dissected free from the 
brain at the level of the median eminence as a cube of tissue weighing 
approximately 3.0 ng. Monitoring glucose oxidation in normal and CTG 
treated tissue cubes indicated that 75Z of each tissue cube contained 
neuronal element* vulnerable to CTG, Histological examination confirmed 
this observation. Two tissue cubes (caps) were placed in culture 
ve**el* (25 ml Erlenmeyer fla*k* with a gas trap), containing 1.47 ml of 
medium and 7.5 uCi of uniformly labeled D-glucose. The incubating 
media was artifical cerebral spinal fluid and prepared according to 
Jones et al. (1975). The vessels were supplemented with 1-2 «Unite or 
10 Units of insulin in a small volume, 45 wl of 8.0 mH ouabain or an 
equal volume of saline. Other vessels possessed no tissue but contained 
insulin, ouabain or saline, and served as controls for auto-oxidation of 
the D-glucose. All vessels were sealed with rubber septum* and 
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gassed for 30 seconds with • 95% oxygontSZ carbon dioxide mixture. The 
VNH caps were allowed to incubate with saline, ouabain or insulin in the 
media for 30 minutes at 37**C. After the addition of [**C] D-glucose, 
the incubation was continued for 90 minutes. The reaction was stopped 
amt the carbon dioxide released by the addition of 9.0 N sulfuric 
acid (1.2 m^l) to the media. Nyamine (0.5 ml) was added to the gas trap 
to absorb the [**C) carbon dioxide and incubated for an additional 60 
minutes. The hyamAne was collected from each vessel and counted by 
liquid scintillation with a tecknan 250 liquid scintillation counter. 
As a test for tissue viability, saline vessels with hypothalamic tissue 
were supplemented with 15 ul of 2 mM dinitrophenol in an aqueous 
solution and processed as described above. Experimental treatments were 
done in quadruplicate. The t-test was used to test for statistical 
significance. 
Result# 
Ouabain had no effect on glucose oxidation in the VNH (Figure lA). 
This evidence indicates that glucoee transport is not dependent on a 
cotransport mechanism with the sodiw#-potassium pump. Glucose oxidation 
in VMB caps from diabetic mice was not enhanced by the presence of 
insulin (Figure IB and C). Physiological concentrations (Figure IB) or 
pharmacological amounts (Figure IC) of insulin did not alter glucose 
oxidation in these diabetic VHR tissue caps. It is noteworthy, however, 
that untreated, normal tissue caps displayed a emch hi^ier glucose 
oxidation rate than alloxan-diabetic tissue caps (p<0.00l). No 
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significant diff#f#nc* existed between the controls in the two insulin 
experiments (Figure IB and C). This point will be discussed below. The 
presence of dinitropherwlt an uncoupler of oxidative phosphorylation» in 
the incubation media caused glucose oxidation to greatly increase 
(10.8 X 10"* moles glucose oxidixed/mg tissue/hour), a process analogous 
to the Pasteur effect. While not unexpected, the response to 
dinitrophenol poisoning indicates that tissue viability was not impaired 
during incubation. 
Discussion 
Studies ^  Likuski et al. (1967) have shown glucose may play a 
major role in determining satiety. Autoradiographic technique* 
demonstrated CTC and non-necrotising analogs of CTC become localized in 
the vm but only C7G caused a Vlffl lesion. These results indicated that 
the effect of CTC is not due to the toxicity of the gold or sulphur 
moiety* or failure to penetrate the blood-brain barrier (Likuski et al., 
1967), but that glucoae is of prime importance in the development of 
(«Kf-induced pathology and possibly satiety. 
Glucose transport and oxidation in the VMH are not coupled with the 
sodium-'potassium puny mechanism. This evidence, however, does not 
eliminate the possibilty that the sodium-potassium pump may be involved 
with satiety. Intrahypothalamic injections of phlorizin, an inhibitor 
of glucose transport and oxidation, are known to prevent the hyperphagia 
and obesity caused by o CTG challenge (Debons et el., 1974a). The 
phlorisin apparently interferes with the development of the CTG-induced 
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fMcrosis in th* VMM. Preliminary work in our laboratory indicates that 
intrahypothala^c infusions of ouabain do not provf t the CTC-induced 
lesions seen in the VMM. This observation supports the idea that the 
sodium-potassium pump is not involved with CTC necrosis and perhaps 
satiety. 
The action of glucose with possible VMM satiety mechanisms requires 
insulin (Debons et al., 1969; 1970; 1977). Our data, however, suggest 
that glucose transport and oxidation do not require an insulin-dependent 
mechanism. The diabetic condition imposed upon the tissue would be 
expected to enhance any insulin effects when ccmpared to normal tissue. 
This result is in agreement with the work of Coodner and Berrie (1977). 
They demonstrated that normal hypothalamic tissue failed to respond to 
insulin in vivo and in vitro. Their explanation for this paradox 
suggested that, (a) insulin nay act indirectly on the hypothalamus via 
neurons from the circumventricular organs (the median eminence 
apparently does take up insulin), or (b) the permeability of the blood-
brain barrier may possibly be altered by insulin, enhancii^ the rate of 
glucose transport into the CMS. 
Alloxan has been used as an effective diabetogenic agent; a large 
dose will destroy the beta cells of the pancreas and limit insulin 
secretion (McEvoy and Begre, 1977). Prior treatment of the beta cells 
with D-glwcose will protect them from alloxan damage (McOaniel et al., 
1976). This result suggests that alloxan competes with glucose for 
receptors in the cell membrane. Systemic injections of 2-deoxy-D-
glucose (2DG) are known to cause hyperphagia (Smith and Epstein. 1969), 
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and inhibit GTG n#cfo#i@ in the VMH (Likuski «t al., 1967), presumably 
by competing with glucoae transport mechanisms. Recently# 
intraventricular injections of alloxan were found to abolish the 
hyperphagic response induced by 2DC, suggesting a competition between 
alloxan and 20C for receptor sites in the brain (Woods and McKay, 1978). 
Woods and McKay (1978) reported that alloxan treatment eliminated 
the 20C hyperphagia response for weeks. The cellular receptors 
sensitive to 2DC and glucose appeared permanently altered by alloxan. 
Our data support this finding. VMH tissue caps, previously treated with 
alloxan by a single intravenous injection, cannot oxidize as much 
glucose per unit as normal VMH tissue caps similar in weight (comparison 
of control in Figure IA with controls in Figure IB and C). The alloxan^ 
diabetic tissues exhibit a 66% depression in glucose oxidation with 
reapect to normal tissues. This alloxan-induced decrease in glucose 
oxidation is highly significant (p<0.00l). 
As early as three days following alloxan treatment, the cell 
membrane# in the Vm are apparently altered (McOaniel et al. 1976>. 
Glucose transport properties and/or receptor mechanism# in VMH membrane# 
seem to be deficient following alloxan treatment. Reduced glucose 
oxidation rates in alloxan-diabetic VMS caps support this conclusion. 
Figure I. A. The effect of saline (COW) and ouabain (OUA) on the 
amount of glucose oxidised by normal VMH tissue. B. The 
effect of saline (CON) and 1-2 #U of insulin (INS) on the 
amount of glucose oxidized by alloxan-diabetic VHB tissue. 
C. The effect of saline (CON) and 10 U insulin (INS) on the 
amount of glucose oxidised by alloxan-diabetic VMB tissue. 
The bars indicate the mean of four experiments (eight mice) 
S.D. No significant difference was found between the saline 
control and ouabain treatment or saline controls and insulin 
treatments 
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CHAPTER k. THE EFFECT OF DXGITOXOSE ON FEEDING BEHAVIOR 
Introduction 
Mayor (1953) profofod tho original gtucoctat hypothocia of feeding 
behavior on the baaia of gold thioglucoae (GTC) vulnerability of the 
ventromedial tqrpothalamua (VNH) coupled with aubaequent hyperphagia, 
Theie data auggeated that a aechaniaa for regulating food intake, which 
waa aenaitive to glucoae analoga, waa located in the VHH. GIG 
aenaitivity in the VKH and aubaequent leaion formation can be inhibited 
by ayatenie injectiona of 2-deo»y«D»glucoae (20C) (Likuahi et al,, 
1967). 20C ia a competitive inhibitor of glucoae utilization (Micka et 
al., 1955b; 1957), which alao inducea hyperphagia (Likuaki et al., 
1967). Phlorizin, a competitive inhibitor of glucoaa tranaport 
(lotapaich, 1961), alao will bl4xk GTC necroaia in th# VW (Debona et 
al., 1974a; Brown and Vilea, 1902) and induce hyperphagia (Click and 
Mayer, 1968). Pharmacological manipulation of Vm glucoae utilization 
may affect feeding behavior. Smith and Epatein (1969) have pressed a 
glucoprivic mechaniam for the control of feeding behavior; brain 
glucoreceptor* atimulate feedii^ when their glucoae utilization is 
diminiahed. Since Harrazzi (1976) haa demonatrated the preaence of 
glucoae-senaitive neurona in the VHH, a glucoreceptor ayatem may exist 
in the Vlffl which is important in controlling food intake. 
4? 
However, specific GTC vulnerability in the VMH has not been widely 
accepted. Liebelt and Perry (1967) presented evidence that the CTC-
induced VMM lesion is nonspecific. They noted that other hypothalamic 
and extrahypothalanic nuclei can be damaged by GTC# and attributed this 
general destruction to blood-brain barrier damage, Caffyn (1971{ 1972a) 
examined CTG-induced lesiona by electron microscopy and concluded that 
GTC caused capillary damage, resulting in increased capillary 
permeability and subsequent downstream ischemia. These conditions 
produced edema and cellular damage. Levin# and Sowinaki (1982) found 
that the triamine, 3,3' met)^lifltinobis-(tt-methylpropylamine), produced 
V)W lesiona very similar to those of (HG, even though the compounds are 
structurally unrelated. This evidence suggested that GTC is a drug 
which causes nonspecific lesions of the VMS via vascular damage. 
Recently, Young et al. (1979) have observed that, while regions of 
the hypothalamus other than the vm may be affected by GTC, the median 
eminence is not damaged. They concluded that GTC may have a specificity 
for certain hypothalamic structures and suggested (^C lesiona might 
result from impairment of glucose uptake and utilisation the VHH. 
Debona et al. (1979b) have demonstrated that damage to the VW neuropil 
in the pericapillary regions occured prior to observable capillary 
damage and is restricted to a small area of the VHH. They have 
suggested that GTC is a specific neurotoxin, damagir^ target neuronal 
structures in the VHB before ischemia and edema develop. 
Recent studies of VMB glucose oxidation in vitro have revealed that 
several glucose analogs (Brown and Viles. 1985), including 2DC, and 
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inhibitor# of glucos* transport» such as phlorixin (Brown and Vilas. 
1982), do not inMbit glucosa oxidation significantly axcapt at vary 
high concentrations. This raault is consistant with tha observations of 
Likuski et al. (1967) that large doses of 2DO are required to block CftG 
lesion formation in the Vlffl in vivo. Brown and Vilas (1982) have shown 
that large systemic doses of phlorizin also were required to block CTG 
lesion formation in the Vïffi in vivo. However, the hi^ concentrations 
of these inhibitors necessary to affect VMR glucose oxidation in vitro 
suggeat that these compounds are not very effective inhibitors of 
glucose oxidation, and possibly iwt highly competitive glucoreceptor-
binding analogs, at least in the VMH. 
The sugar digitoxose, 2,3-dideoxy-ribohexose, part of the cardiac 
glucoside digitoxin, has been shown to inhibit glucose-stimulated 
insulin release from the pancreatic islets without affecting glucose 
oxidation in the beta cells. Garcia Bermida and Gomes-Acebo (1975) 
attributed this phenwienon to the interaction of digitoxose (DIG) with a 
glucoreceptor in the beta cell membrane, which did not interfere with 
glucose transport or oxidation. THia proposal suggested two pathways 
for glucose utilization in thia system; one affecting stimulus-
secretion coupling and the other providii^ glucose for energy 
utilisation. 
In this study, DIG wa@ used as a chemical probe to test several 
aspects of VMB glucose sensitivity for evidence of differentiated 
glucose utilization, as proposed for the pancreas. The experiments 
included: 1) measuring the effects of DIG on feedii% behavior as an 
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indicator of modulation of feeding behavior, 2) th« effects of DIG on 
CTC-induced necrosis as an indication of inhibition of GtC binding in 
the Vtn, and 3) the effects of DIG on VHH glucose oxidation as an 
indicator of inhibition of glucose utilisation. 
Materials and Methods 
Cn female mice, weighing 20-25 were used for these 
experiments. The #^ce were fed Teklad Rat and Mouse Diet and given tap 
water freely. A photoperiod of 12 hours lightt12 hours dark and an 
environmental tesfierature of 23*C were maintained. A 1000 mgAg DIG 
dose was given. If more than one injection was used, the first 
4 injections were given at 3-hour intervals. Subsequent administrations 
were given every 6 hours. GTC was given in a dose of 300 a%/kg. All 
injections were given intraperitoneally. The Mann-Whitney U and t-test 
were used to test for significant differences. 
Feedii* Behavior 
Mice were assigned randomly to two groups; normal and obese. 
Within each group were controls (water injections, n»4) and 
experimentals (DIG injections, n»4). Since food intake can vary 
tremendously between the lifpit and dark periods, the effects of DIG were 
assessed under both light and dark conditions. Under dark conditions, 
all injections and weighii^s were done with red light. To enhance 
feeding, the animsls were deprived of food for 18 hours prior to 
experimentation (Latham and Blundell, 1979). The light and dark 
experiments were begun 2 hours after the end of the previous 12-hour 
so 
photopcriod. The control (water) end DlC injections were given 
IS minutes before food (Teklsd Rat and Mouse Diet) was made available, 
and at 1000 hrs for day experiments and 2200 Mrs for night experiments. 
Obese mice were derived from normal mice given a CTG injection. These 
GTG-treated mice were judyd obese if they weighed at least 2S% more 
than their uninfected littermates 6 weeks postinjection. Total food 
intake and group body weight were monitored every hour for the 6-hour 
period. To determine whether or not ttM animal colof^ was responsive to 
drug-induced alterations of food intake, mice were selected at random 
from the stock colony, injected with 2DC (300 mg/kg) at approximately 
1(X)0 hrs, and monitored for hyperphagia. All of these 2DG-treated mice 
(n«8) became hyperphagic. The mice were thus considered responsive to 
drug-induced chaises in feeding behavior* 
PIC and (?TC Interaction 
DIG was injected 30 minutes before the CTC injection, between 1000 
and 1200 hrs. After the CTC injection, the mice (n»10) were 
subsequently injected with DI(ï at the appropriate intervals, A total of 
6 DIG injections were given. Control animals (n»10) were given ^ 2^ 
instead of DIG. The mice were decapitated 24 h<Nirs after the CTG 
challenge. The brains were removed from the skull, fixed in Bouin's , 
fluid, dehydrated, and embedded in paraffin. Seven-micron thick 
sections were made through the VW at the level of the median eminence 
and stained with hematoxylin and eosin. The vm was examined for 
lesions by light microscopy. 
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In vitro Cluco»c Oxidation Studt»» 
Animala wara daeapitatad in the morning and tha VNR was dissactad 
fraa fro# tha brain at tha laval of tha madlan aninanca aa a cuba of 
tisaua. Two VMM tiaaua cubaa (caps) wara placad in a eultura vassal (a 
Erlaimayar flask with a gas trap; (#6) containing 1.47 ml of 
madius, 7*75 ag DIG in BgO, and 7.5 u€i of aquaous uniformly labalad 
D-glucoaa. Control vassals <na6) contained salina instead of DIG. 
Tha incubating medium was similar to cerebral spinal fluid and prepared 
according to Jonas at al. (1975), Other vessels possessed no tissue and 
served as controls (n#6) for auto-oxidation of the [^^C] D-glucose. All 
vessels were sealed with rubber septums and gassed for M seconds with a 
95% oxygen;5% carbon dioxide mixture. The caps were allowed to incubate 
15 minutes with DIG in ttw medium at 37^C. After the addition of 
D-glucose, the incubation was contimted for 90 minutes. The 
reaction was stopped and the COg released by the addition of 9.0 N 
NgSO^ CO.2 ml) to the medium. Myamlne (0.5 ml) was added to the gas 
trap to absorb the (X)^ and incubated for an additional 60 minutes. 
The byamine was collected fro# each vessel and emissions counted 
with a Beckman 250 liquid scintillation counter. Aa a teat for tissue 
viability, saline vessels with hypothalamic tissue were supplemented 
with 15 ul of 2.0 mN dinitrophenol in an aqueous solution and processed 




The effect of DIG on short-cer» feeding behavior (a 6-hour 
interval) was examined umter light and dark conditions. DlC was not 
effective in significantly altering food intake in the dark. However, 
in the light DlC reduced short-term food intake significantly, p<0.01 
(Table I). The effect of DIG on short-term feeding was also tested in 
mice made obese with GTC. DlC had no effect on short-term feeding in 
CTG-lesioned, obese mice during the light. Thus, the reduced food 
intake observed in normal mice in the light was abolished by a C7G 
challenge. 
Normal mice responded typically to changes in the photopertod; more 
food was consumed at night than during the day (p<O.Ol>. Also, the 
obese mice ate more food than the normals (p<O.Ol). 
PIC Inhibition of CTC Necrosis 
DIG injections did not alter the vulnerability of the VKH to GTG 
administration. Mice injected with either DIG and CTC or water and GTC 
exhibit GTC lesions of similar dimensions (Figure I). No si^ficant 
difference existed in lesion size between the two treatments, as 
determined by planimetry. 
In addician, preliminary data indicate that DIG infused into the 
VHH did not interfere with GTC necrosis. These intrahypothalamic 
infusions of DIG did not eliminate or alter size of the <»TG lesion. 
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In vitro Glucom# Oxidation 
DIG anhancad glucoaa oxidation in tha VNR by alsoat 13% at 
concantrationa 3 tinaa graatar than glucoaa in tha incubation medium 
(figura 2). Rowavar» thia diffaranca waa mt aignifieant. Tha affaet 
of dinitrophanol, an uncouplar of oxidative phoaphorylation, waa aimilar 
to that obaervad earlier (Brown and Vilea* 1980* 1982), Glucoae 
oxidation increaaed approximately threefold, indicating that glucoae 
oxidation pathway# and regulatory mechanism# were atill functional. 
Discussion 
In this atuify, it haa been demonatrated that the sugar DIG haa no 
effect on (TM-induced lesion formation in the VNH, and in vitro glucose 
oxidation in VIM tissue, iowever* DIG injections <Ud <tocrease daytime 
food intake significantly without affecting nocturnal feeding behavior. 
Debons et al, (1968; 1969; 1970) have shown that Vm vulMrability 
to (yiC-induced necrosis is insulin-dependent; diabetic mice are 
resistant to CTG lesion formation. DIG has been shown to inhibit 
glucose-stimulated insulin release from the pancreas (Garcia Hermdda and 
Gomes-Acebo, 1975). Tinta, if DIG decreaaed insulin levels sufficiently. 
(#IG lesion formation should be inhibited in DIG-treated mice. However, 
DIG injections did not prevent the development of a GTG-induced lesion 
or alter the sise of the lesion, nor did an intrahypothalamic infusion 
of DIG, The possibilities of DIG binding com^titively to GTG-sensitive 
neural tissue or diminishii^ insulin secretion, and thereby inhibiting 
GTC lesion formation, is not supported. 
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VHB cap# incubatcd in vitro with DIG showed no inhibition of 
glueoso oxidation; instead they showed an enhanced (albeit 
insignificant) glucose oxidation rate, about 13% greater than the 
controls. Garcia Rermida and Gomez-Acebo (1975) observed a similar 
enhancement of glucose oxidation in pancreatic islets treated with DIG. 
This evidence suggested that DIG is not an effective inhibitor of 
glucose oxidation in the VMH, as has been observed with a number of 
glucose analogs (Brown and Viles, 1985). Indeed, phlorizin, an 
inhibitor of glucose transport, showed a significant potentiation of VMM 
glucose oxidation in vitro, but only at a low concentration (Brown and 
Vile#. 1982). 
DIG sifpiificantly reduced food intake in miee during the light 
photoperiod, but had no effect on feeding in the dark. It miight be 
expected that an effect would bo more noticeable with darkness, since 
mice consume tho majority of th#ir food at night. However, this 
photoperiod-dependent difference in feeding behavior could be explained 
by a hypothalamic circadian rhythm. The suprachiasmatic m*cleu# in the 
hypothalamus, an area associated with the control of diurnal variations, 
selectively bound 20C duri#% the day but not at night (Schwartz and 
Gainer, 1977). In addition, tarue-Achagiotis and LeHagnen (1979) have 
shown that a 2DC challei^e inhibited food intake at night but stimulated 
feedii^ during the day. The daytime result# from their study (Larue-
Achagioti# and LeMagnan, 1979) are incongruent with our data. This 
inconsistency may be linked to the ability of 20C to be a glucoprivic 
stimulus, while DIG is not. Ritter et al. (1981) have demonstrated that 
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the glucorccoptors rcsponsibla for oliciting hyperphogia, under 
condltiona of glucoprivation* are located in the hlndbrain and not in 
the hypothalanua. A glucoprivie atimilu* reaulting frma the 
adniniatration of 20C or 5-thioglueoie (5TC) is known to produce an 
iiwreaae in food intake (Hitter et al., 1981). These two compounds also 
inMhit GfC lesion formation, presuMbly by binding to VfM 
glucoreceptors (reference for 2DC-Likuski et al., 1967; 5TC-Brown, 
1983). Since DIG has an opposite effect on feeding behavior compared 
with these glueoprivie compounds and DIG has no effect on CKï-induced 
necrosis in the VKM, apparently DIG cannot be described as a substance 
capable of inducii^ glucoprivation or binding to hypothalanWLc 
glucoreceptors. DIG probably does not affect daytime feeding behavior 
by a central mechanism. 
Garcia Hermida and Gomes-Acebo (1875) ^ monatrated that DIG 
affected glucose-stimulated insulin secretion, presumably binding to 
beta cell membrane glucoreceptors. It has been well-documented that 
peripheral hepatic glucoreceptors play a role in the regulation of 
feeding behavior (Novin et al., 1973* Russek, 1970). The exact 
mechanism is unclear, but these peripheral glucoreceptors may produce 
feeding and/or satiety signals, which are relayed to the brain via vagal 
afferent# (Niijima, 1969). Phlorizin, when infused intraventricularly 
into the brain, produced hyperphagia, apparently by binding to central 
glucoreceptors (Glick and Mayer, 1968). An infusion of phlorizin into 
the liver decreased the vagal afferent discharge rate, probably by 
affecting hepatic glucoreceptors (Niijima, 1969). Furthermore, 
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Infusions of 20C into Kho hepatic portal system stimulated feeding 
(Novin at al., 1973* Russek, 1970). Since DIG is known to affect 
insulin secretion via glucoreceptors, it is conceivable that DIG may 
affect other peripheral glucoreceptors, such as those found in the 
liver. Thus, our observation that DIG inhibited daytime feeding 
behavior may be due to a diurnal alteration of vagal afferent discharge 
mediated by hepatic glucoreceptors. Further investigations are needed 
to explore this possibility. 
Figure 1. Cross section# of mouse brain, depicting the VKH at the level 
of the median eminence, 24 hrs after a CTC challenge. 
A. Water given IP initially followed by CTC (300 ng/kg) IP. 
t. Die (1000 ng/kg) injected IP followed by 300 ng/kg CTC 
parenterally. Bar equals 1,0 am 

Figure 2. The effect of DIG on glucote oxidation in the VHK in vitro. 







TABLE I. The effect of digiCo«ose (DIG) of focMl intake in food-deprived mice in li^t or dark 
Nonosl nice food intake 
Cgo/^ body weight, mean + 
Water (Control, n*4) Dig Tn®<i) 
GTC obese mice food intake 
(gm/gm body weight, mean + SEN) 
Water (Control, n»4t) OIC Tn=4) 
Light 
(Range) 
0.008 + 0.005 
(0.085:0.092) 
0.073 • 0.007 
(9.064:0.077) 
0.132 + 0.048 
(0.08QM9.176) 




0.108 + 0.012 
(0.096:0.119) 
0.111 + 0.012 
(0.103:0.125) 





CHAPTER 5. TRYPTOPHAN EFffCTS ON GTC-INDUCEO 
VENTROMEDIAL HYPOTHALAMIC NECROSIS 
Introduction 
Cold thioglucoao (CTC) ho# boon uaed Cor ovor 30 year# a# a moan# 
of Inducii^ obesity in experimental animal#. Thi# obe#ity #yndrome i# 
believed to be cauaed by ClC-induced necroai# of the ventromedial 
hypothalamus (VMH), but the meehanian of GTC action in the hypothalamus 
haa remained an enigma. Recently, htwever, aerotonin (5-
hydroxytryptamine, 5RT) has been implicated in mediating OTC lesion 
formation in the vm, 
Debons et al. (1978; 1979a) have presented evidence sug^sting that 
the develi^went of VNH lesions induced by GTC is mediated by 5KT 
release. Drugs that depleted SHT stores or antagonized 5HT action 
prevented CTO»induced necrosis in the VMH. Although 5HT abnormally 
increases capillary permeability (Sparrow and Uilhelm. 19)7), (nc« 
induced necrosis of the VMH can occur without structural capillary 
damage (Debons et al., 1977; 1979b). The VNH has a high level of 5HT 
(Brownstein et al.. 1976), and GTC apparently damages serotonergic 
neurons causing a release of 5HT, This 5HT release, in turn, damages 
the adjacent capillaries as a consequence of t*w neuropil destruction 
induced by (ÎTG. These damaged neuronal components are possibly those 
involved with the reputed satiety function of the VHH (Blundell, 1977). 
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Caffyn (1972a and b) also obsarvsd hypothalamic edema associated with 
the GTC injection. Prevention of 5HT mediated edema inhibited GTC 
lesion formation, even though VMH levels of 5HT are high (Debons et al., 
1979a). These data presented by Debons et al. (1977; 1978; 1979a; 
1979b) support the ideas that (1) GTG-induced necrosis is not produced 
by vascular damage as proposed by Caffyn (1971; 1972a), but by a toxic 
flood of released from damaged neuronal cells and (2) CTC can serve 
as a useful probe for hypothalamic function. It follows that the 
precursor of SHT, tryptophan (TRP), could influence CiTG necrosis in the 
Vim. 
TRP, an essential amino acid, is normally supplied to animals 
through the diet. A high fat diet (Curzan and Knott, 1974; Hyyppa et 
al., 1977), insulin injections (Fernstrom et al., 1974; Mackenzie and 
Trulson, 1978), fastis (Fernstrom et al., 1974; Curzan and Knott, 
1974), and malnutrition (Miller et al., 1977) are all known to increase 
TRP levels in the brain. Since the rate limiting enzyime in the 5HT 
synthetic patWay, tryptophan hydroxylase, is not saturated with 
substrate under normal conditions (Growdon, 1979), en increase in brain 
TRP would be expected to increase brain SMT levels (Marsh et al., 1979). 
Thus, each of the above diets or physiological nurtitional states would 
increase 5MT levels in the central nervous system. Low levels of TRP in 
an otherwise normal diet should cause decreases in brain 5HT content. 
Sahakian et al. (1979) have shown this condition to be true. 
The evidence for the involvement of 5HT in the control of feeding 
behavior is strong (Blundell, 1977; Blundell and Latham, 1979). The 
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precursor of SUT, TRP, surprcsacd food intak* when injected in rats or 
mice CBlundell, 1977% Latham and Blundell, 1979). Presumably this 
effect is brought about by the metabolism of TRP to 5HT (Latham and 
Blundell, 1979). It is conceivable that factors controlling StfT 
metabolism may influence the responsiveness of the VMM to (#TC. The 
production of is dependent on the presence of the precursor TRP. As 
mentioned earlier, since TRP is an essential amino acid and must be 
supplied through the diet, the amount of TRP ingested may influence the 
metabolism of TRP snd 5HT. 
These f^ysiological and mitritional states, reflecting increased 
blood and brain TRP levels, may be related to GTC hypothalamic 
vulnerability. The availability of TRP for the production of 5NT in the 
central nervous system could be a primary factor in CTC lesion 
formation. Recently, Young et al. (1979) have shown that mice 
Nwintained on a high fat diet, versus normal chow or high carbohydrate 
diet, have significantly larger CTG-induced VMM lesions. They 
postulated that the high fat diet resulted in peripherial glucose 
intolerance causing elevated blood levels of GIG or glucose. An 
alternative explanatim* for the increased sensitivity of the Vm to CTO 
in mice fed a high fat diet is plausible. Th« increased level of 
nonesterified fatty acids in the blood ftom the high fat intake 
resulting in an increase in SBT brain content (Fernstron ec al,, 1974; 
Pardridge, 1977), could result in more extensive damage to the vm due 
to a GTC challen^, since SHT is implicated as mediating the (^^induced 
VMH pathology (Debons et al., 1978; 1979a). 
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If high levai* of THP and SlfT can increase VNH vulnerability to 
GTGt then low TRP levels may depress (TTC necrosis in the VHH. Brain ÎRP 
levels are low in diabetics (Mackenxie and Trulson, 1978). The 
resulting decreased brain SNT content may depress the susceptability of 
the VNH to CTC to such a low level, that necrosis is inhibited in 
diabetics. Debons and co-workers (1968) discovered that a CTC injection 
in diabetic mice caused no necrosis of the VMM, suggesting that VNH CTC 
sensitivity re<|uried the presence of insulin. Injections of insulin 
increase brain TRF content (Nackenaie and Trulson, 1978). The insulin 
administration reported by Debons et al. (1969* 1970), to reverse CTC 
insensitivity of the VMM in diabetics nay be due to increased iWT 
synthesis, mediated by an increased brain TRP concentration. 
Since TRP (Latham and Blundell, 1979) aiW probably SUT (BluiWell, 
1977; Blundell and Latham, 1979) level* are correlated with food intake, 
manipulations of TRP in the daily diet could possibly be a means of 
controlling hypothalamic GIC sensitivity in normal or diabetic mice. 
Materials and Method# 
General Description 
Female CPl atiee, weighing between 20-25 gm, were used in this 
study. The mice were maintained at 23^C with a 12 hour light: 12 hour 




ExporiMfits war# either short term (24 hours or less) or long term 
(more than 24 hours). TRP in an aqueous suspension was given in two 
doses, 150 or 400 mg/kg intraperitoneally (IP); GTC was injected IP in a 
dose of 300 mg/kg. TRP administration (3 infusions) varied from 3 hour 
to 8 hour intervals, during the short term studies. Long term 
experiments had 1 TRP injection per day. Controls were given water and 
CTC. 
Nice were decapitated 24 hours after CTC injection. The brains 
were removed from the skull, fixed in Bouin's fluid, dehydrated, 
embedded in paraffin, sectioned at 7 urn, stained with hematoxylin and 
eosin, and examined by light microscoRf. The size of the lesion was 
determined tqr tl» method described by Youi% et al. (1979). Briefly, the 
cross sectional area of the lesion at its largest point was measured 
using a planimeter and an overhead slide projector at a magnification of 
46 times. The t-test was used to determine significant differences. 
for rapid lesion detection and empirical comparisons between 
experimental treatment* and controls, brain# fixed in Bouin's fluid were 
separated at the level of the median eminence and the presence or 
absence of a lesion determined with a dissecting microscope. 
Diabetic Animals 
Diabetes nellitus was induced by sn intravenous injection of 
alloxan (150 The diabetic condition was confirmed 3 days post 
injection using Clinistix as an indicator of glucose in the urine. An 
aqueous suspension of TRP was given IP (200 mg/kg) or IP and orally (400 
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og/kg) (SCO Results for mor# details). 
Results 
Normal Animals 
All normal TRP treated animals (IP or oral) and controls in the 
short term experiments challenged with GIG* exhibited lesions of similar 
dimensions upon light microscopy inspection. The dose of TRP (4(X) mg/kg 
IP) and interval between the 3 TRP injections appeared, empirically, to 
have no effect on GTC lesion formation in the VMM. Planimetry of a 
short term experiment with TRP given orally confirmed this observation 
(Table I and Figure 1). No significant difference in lesion size 
existed between TRP-treated and control animals. 
Long term experiments produced varied results. The experiment 
using oral TRP injection# (1% mg/kg) for 7 days did not produce any 
sise difference# in tho VWi lesion between TRP-treated and control 
animal# (Table 11). The lo*% term study lasting # day# produced a 
significant reduction in lesion sise between experimental# and control*. 
These mice* receiving the TRP (ISO mg/kg IP each day), displayed much 
smaller VMM lesion# induced GIG than the controls (Figure 2 and Table 
III). 
Alloxan Diabetic Nice 
Diabetes mellitus prevent# GTC necrosis in the VNW via insulin 
deficiency. Animals given TRP (200 mg/kg/day IP), during the 
development of the diabetic condition (3 days), and challenged with GTG 
did not exhibit GTG necrosis in the VHU (Table IV). Two series of TRP 
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(400 IP only or IP and oral) injection# adninistarcd at a 7 hour 
interval to 3 day alloxan diabetic# also caused no change in the 
expected reaponae to CTC, which was given 4 houra after the first #et of 
TRP injection# (Table V). No CTC lesion# were ob#erved in the VKH. TRP 
was unable to reverse the inhibition of CTC lesion formation in the VMH 
due to the absence of insulin. 
Di#cu«#ion 
Debon# et al. (1979a) have shown that )NT ia a potential mediator 
of (nc necrosis in the mouse VMM. (Ganges in the 3HT content in the 
hypothalamus would be expected to alter the responsiveness of the VMI to 
CTC. TRP loading increases the content of TRP and SUT in the brain 
(Wurtman and fernatrom* 1974; Crowdon and Wurtman, 1979), there*# 
increasing the probability of a larger VMH lesion due to a G7C 
challenge. Supplements of TRP. however, did not cause an increase in 
lesion sise followii^ a (STC challei%e, but rathor exhibited no effects 
on lesion siae and in one experiment caused a reduction in lesion size. 
The rate of 5BT turnover may have an effect on vm sensitivity to 
CTC. When the SUT content of the brain is increased, the turnover rate 
of 5BT i# accelerated (Cessa and Tagliamonte, 1974), Chronic injection# 
of TRP increase TRP hydroxylase activity in the brain, however, TRP 
levels are not hi^er compared with control* (Diez et al., 1976). A 
rapid turnover rate of 5MT would, in effect, cause the cellular pools of 
5UT to remain constant or perhaps decrease in the presence of high TRP 
levels. Thus, levels of brain 5HT in animals receiving TRP 
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aupplARwntation could b« aimilar to the controls. Mackenzie and Trulson 
(1978) have shown this phenomenon to be true. Manipulations that caused 
changes in brain TRP concentrations produced no alterations in 3HT 
metabolism. GTC-induced VMH lesions of similar or smaller size might» 
therefore, be expected in both the controls and the animals receiving 
TOP. 
In no instance did TOP administration produce an increase in the 
size of VMM lesions due to GTC. However* in the 8 day long term study, 
TOP caused a significant decrease in the size of CTC-induced VMH 
lesions. TOP loading over an 8 day period may accelerate the turnover 
of SHT in the brain. As iaqtlied by Dies et al. (1976), this increased 
SifT turnover rate may have resulted in a relative decrease in 5HT 
content in the VMM. The SHT reduction, Wt not depletion, could account 
for the smaller lesions in tW 8 day TOP injected mice. Indeed, 
Eecleston and Hicolaou (1978) have shown that rats given TOP displayed 
an increased 5HT turnover rate. Oral TRP in either short or lo% term 
experiments showed no effect on GTC lesion formation in the V##*. The 
reasm for this difference is unclear, however, the intragastric loads 
of TRP may not have been completely absorbed, thereby decreasing any 
systemic TOP effect. 
Diabetes prevents the occurrence of GTG-indwced pathology in the 
mouse VMH (Debons et al,, 1968; 1969; 1970). Diabetes also causes a 
decrease in brain TRP concentration*. Increasing brain TRP levels may 
produce a vm sensitivity to GTC. Our results demonstrate that TRP 
treatment does not alter VHH vulnerability to CTC in diabetic mice. 
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However, insulin administration will cause a return o( CtC lesion 
formation in diabetics (Debons et al# 1969; 1970). Insulin injections 
also produce an increase in brain TAP levels withmit a change in 5HT 
metabolism (Nackensie and Trulson, 1978). Since even TRP levels appear 
to have no effect on SKT concentrations at least with respect to CTG 
lesion formation in diabetics* sensitiaation of the diabetic Vtffl to CTG 
with insulin is the foundation for GÎC lesion formation in this model. 
5NT and TRP do not appear to contribute significantly to the alteration 
of the VMH sensitivity in diabetic mice. 
Debons et al. (19798) have shown that SUT acts as a mediator for 
CTC lesion formation. Since TRP is the nutritional percursor for this 
neurotransmitter, we investigated whether or not TRP loading had any 
effect on CfC lesion formation. Our results suggest that TRP and SWT 
play a role in CTG-induced necrosis in the mouse VIM but that this role 
may be overshadowed by hormonal influcenees. 
Figure I. The effect of oral TRP on a short term basis on GTG lesion 
formation* A» Control—a cross-section of the Vtffl at the 
level of the median eminence from a mouse given water orally 
and challenged with GTG. B. A cross-section of the VMM at 
the median eminence level from a mouse treated with TRP and 
subsequently given CW, No significant difference exists 
between the water and TRP treatments 
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Figure 2. Th« effect of long term TRP (ISO mg/kg/day for 8 deyt) 
treatment on GTG lesion formation. A. Control—«a cro##-
section of the at the median eminence level from a mouse 
given water orally and challenged with GTG. B. A cross-
section of the vm at the level of the median eminence from o 
mouse treated with TftP and challenged with G7C. The TRP 
treated mice displayed significantly smaller GTC-induced 
lesions compared with the controls. p<0.001 
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TABLE 1, The effect of tryptophan (ÎRP) given orally on short term 
basis on CTC lesion formation 
Treatment n Lesion size 






5.3 * 2.8 
7.4 * 4.5 
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TABLE II. Th« effect of oral tryptophan (TRP) for 7 days on GTG-lnduced 
necrosis in the hypothalamus 
Treatment n Lesion siie 






6.2 * 2.5 
6.0 * 2.0 
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TABLE 111. The effect of tryptophan (TRP) given intraperltoneally for 8 
day# on CTC neeroaia in the VHH 
Treatment n Leaion aize 
(mean * SO) 
iegrx x46) 
Control 12 5.8 ± 2.4 
TRP 12 • 4.0 • 1.3# 
* Significantly different fro# the water control#, p<0.Q01. 
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TABLE IV. Th« «ffcct of tryptophan (TRP) treatment during the 
development of diabetes on GTO lesion formation 
Treatment Incidence of 
Necrosis 
tX) 








TABLE V. The effect of tryptophan (TRP) treatment on CTC lesion 
formation in diabetic nice 
Treatment n Incidence of 
Necrosis 
(Z) 
400 mf/kg TRP—IP only 
Control 3 0 
TRP 2 0 
400 mg/kg TRP—oral and IP 
Control 7 0 
TRP 13 0 
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CHAPTER 6. THE EFFECT OF ALPHA-HETHYLPARATYROSXNE AND TYROSINE 
LOADING ON GOLD THIOGLUCOSE LESION FORMATION 
IN THE VENTROMEDIAL HYPOTHALAMUS 
Introduction 
C#teehol#*in*# (CA) ar« known to hav# profound effect# on feeding 
behavior, Grossnen (1960) we# the first to show thet intreventriculer 
administration of norepinephrine (NE) stimulated hyperphagic activity. 
Injection# of dopamine (DA) had no effect (Leibowitz, 1973). 
Destruction of dopaminergic fiber systems (Rowland et al., 1979) caused 
hypophagia in rats made hyperphagic by ventromedial hypothalamic (Vm) 
electrocoagulation. Cuts made in the ventral noradrenergic bundle 
produced hyperphagia (Gold, 1973; Grossman and Grossman, 1977), 
Treatment of rats with drugs known to deplete central NE abolished 
eating (Leibowits, 197$). On the other hand, opposite effects also were 
found with NE depletors. Leibowits (1975) sug^sted that alpha-
adrenergic receptors stimulated feeding, while beta-adrenergic and 
dopaaergic receptors inhibited food intake. Recent work by Leibowits 
and Rossakis (1979) supports this muXti-receptor idea. Injections of L-
dopa into the perifornical lateral hypothalamus (PLH) suppressed 
feeding. Blockage of the dopaminergic and beta-adrenergic receptors or 
inhibition of dopa decarboxylase reversed the suppression. L-dopa 
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appeared to decrease food intake, in part, increasing CA synthesis in 
specific neurons located in the PLH. 
It i# well-known that destruction of the VMH by gold thioglucose 
(CTG) causes an obesity syndrom# (Debona et al., 1977). Lorden et al. 
(1979) have demonstrated that CTC leaiona produce significant decreases 
in hypothalamic ME and DA. Since levels of DA and NS are high in the 
hypothalaRws (Palkovits et al., 1974), these losses in NE and DA may be 
involved with the hyperphagia observed in GTO treated animals. However, 
Lorden and co-workers (1979) could find no correlation between body 
weight gain and reduction in hypothalamic NE or DA concentrations. 
Recently serotonin (SHT) has been implicated as a mediator of C7C-
induced necrosis in the VHH (Debons et al., 1979a). The (^G lesion may 
result from a toxic flood of 5MT released by damaged cells during the 
initial stages of lesion development (Debona et al., 1979a). However, 
the fact that SHT appears to participate in induced necrosis, doe* 
not rule out the idea that CA may still be associated with increased 
feeding caused VIQ) lesion#. SHT seems to be involved with the 
effects of NE and OA (Blundell, 1979), suggesting the existence of a 
SRT-CA axis. Increases in SHT brain content depressed DA dependent 
circling behavior in mice (Wilson and Pycock, 1976). Injection* of 5HT 
into the nucleus accumben* increased the levels of DA metabolites in the 
area, suggestif^ that DA turnover was enhanced (Pycoek et @1., 1978). 
In vitro studies have indicated that 5HT terminals will take up OA but 
apparently not NE (Berger, 1978). In addition, 5ifT uptake has been 
demonstrated in NE and DA neuron* (Lichtensteiger et al., 1967). 
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Interaction# b#tw««n SNT and CA neuron# may contribute to the 
hyperphagia and obesity resulting froa GTC administration (Coscina et 
al., 1978). 
To further investigate the involvement of CA in the GTC induced 
obesity syndrome, two experiments were done. The effect of tyrosine 
(TYR) a&sinstration on GTG lesion formation in the mouse VMM was 
assessed. TYR is the precursor for CA synthesis, Zn addition, alpha-
methylparatyrosine (AHPT) was given to mice to deplete the brain of CA 
stores and the effect of thia treatment on GT&-induced necrosis in the 
VHH investigated. 
Materials and Methods 
General 
Female CFl mice, weighing between 20-25 gm were used in this study. 
The mice were maintained at 23**G with a 12 hour light *12 hour dark 
photoperiod, fed Teklad Rat and Mouse Diet and given tap water freely. 
Following the various experimental methods described below, the 
mice were decapitated 24 hours after the CT6 injection. The brains were 
removed from the skull, fixed in Bouin's fluid, dehydrated, embedded in 
paraffin, sectioned at 7 im, stained with hematoxylin and eosin, and 
examined by light microscopy. The sise of the lesion was determined by 
the method described by Young et al. (1979). Briefly, the cross 
sectional area of the lesion at its largest point was measured using a 
planimeter and overhead slide projector at a ma^ification of 46 times. 
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The t-fccst was used to test for aignifictnco between TYR or AHPT 
treated animal# and their controls. 
AHPT Treatment 
Aqueous AMPT* an inhibitor of TfR hydroxylase and a CA depletor, 
was given intraperitoneally (IP) in doses of 230 or 330 mg/kg and 
followed by CÎC (400 ng/kg IP) at 2 to 8 hours after AMPT. A 
combination dose of AHPT also was given—350 mg/kg with 173 mg/kg 
administered 23 hours later. (*tG was given within om hour after the 
second AHPT injection. Controls received water and <*ÎQ, 
TYR Loadimi 
Nice were injected with TYR (200 or 400 mg/kg) IP and/or orally 
with a tube as an aqueous suspension* The loi% term e*perim*nts 
involved injections of 200 mg/kg TYR IP and orally (a total of 400 
img/kg) for 6 days, once a day* GTC (300 mg/kg IP) was given on the 
fifth day* 
One short term investigation involving the oral administration of 
400 1%/kg TYR, 4 time* over a 24 hour period at 4 to 9 hour intervals 
was done, CTG (300 mg/kg IP) was injected 3 hours after the first TYR 
injection. 
All controls for the TYR loadii% experiments received the 
appropriate amounts of water and GTC. 
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Results 
Nice given TYR for 6 days orally and IP and injected with GtC 
developed lesions very similar in appearance to controls (Figure I). No 
significant difference in lesion size existed between the TYR-treated 
and controls (see Table 1). In addition, TYR given orally only to mice 
as described above, did not alter CTC lesion sise in the VMB 
significantly (Table IX). 
AMPT planimetry data from all levels were p<wled and analysed. No 
significant differences in lesion sise existed among dose levels. The 
lesions formed in the mice given AMPT were significantly larger compared 
to the controls (p<0.00l) (Table 111 and figure 2). 
Discussion 
GTG causes a distinct VMM lesion and obesity syndrome very similar 
to the obesity phenomenon induced by electrolytic destruction of the 
VMB, Since Rowland et al. (1979) have demonstrated that the 
electrolytic VMH obesity syndrome can be reversed by destruction of DA 
neurons, perhaps alteration in brain CA levels are involved with GTC 
lesion formation in the vm. 
Oral and/or IP TYR administration had no significant effect on (TTG 
necrosis in the VMM. This result implies that increases in CA 
concentrations by TYR loading (Fernstrom and Wurtman, 1974) do not have 
an effect on GTC lesion formation. The lack of a TYR loading effect is 
consistent with the evidence reported by Lorden et al. (1979). 
Although central CA levels in the hypothalamus decrease as a result of 
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Cit* iMcrosis, these lower CA stores could not be correlated with the 
direct effects of GTC, i.e. hyperphagia and obesity* using body weight 
as a monitor. 
Although our data indicate that potential dietary manipulations of 
CA had no effect on GTC necrosis in the VMM, depletion of central CA 
concentrations with AMPT enhanced GTC lesion formation. Animals 
injected with AHPT developed significantly larger GTG lesions in the VMM 
crapared with controls. This finding suggests that CA may be involved 
with the development of GTC-induced necrosis. Since the VHH damage 
apparently is enhanced by the absence of CA, perhaps CA feedback has 
been comproiaised. However, Debons et al. (1979a) have shown that GTC 
necrosis is dependent on the presence of serotonin (SHT) and/or 
tryptophan hydroxylase activity in the VMM, On the other hand, 
interactions between CA and 5MT have been suggested. Biochemical 
(Eccleston and Nicolaou, I978t Pycock et al., 1978) and behavioral 
(Sahakian et al., 1979) evidence support the idea of a 5HT-CA axis. 
Moreover, Berger (1978) demonstrated that cerebral 5MT terminals can 
take up DA on 0 competetive bo*i* with SBT. In the absence of DA, due 
to AMPT treatment, these 5MT terminals might take up more 5HT than under 
normal conditions. Such an increase in 5BT in VMM neurons may account 
for the larger CÎ6 lesions exhibited in AMPT treated animals. In the 
preserve of high CA levels (TYR pretreatment), the amount of SUT taken 
up by the neurons would be decreased. However, if CA turnover is 
increased due to the TYR stimulation of CA synthesis, the level of SBT 
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in th« terminal# may remain relatively constant. Thus, no significant 
change in GTG lesion formation would be observed in TYR treated or 
control animals. 
Figure 1. The effect of TYR loedlng (6 dey# orally end IP) on GTC 
lesion formation. A. Control. A eroaa-aection of the mouse 
VMB at the level of the median eminence. This animal was 
treated with water and challenged with CTC. B. A cross-
section of the VMM at the median eminence level from a mouse 
treated with TYR and challenged with GTC. No significant 
difference exist» between the two treatments (see Table I) 

Figure 2. The effect of acute AMPT treatment on GTC lesion formation. 
A. Control. A crost-tection of the mouse VMH at the level 
of the median ei^nence. This animal was treated with water 
and challenged with GTC. B. A cross-section of the at 
the median eminence level from a mouse treated with ANPT and 
challenged with GTC. The AMPT treated m^ice displayed 




TABLE 1. The effect of oral and IP tyromine (TYR) on GTG-induced 
necrotl* 
Treatment n Lesion tiie 
(mean * SD) 
(cm ; 1(46) 
Control 8 6.2 ^  2.S 
TYR 9 8.6 • 5.1 
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TABLE 11. Tti* effect of short term, oral tyrosine (TYR) on GTG lesion 
formation 
Treatment n Lesion Siie 






5.3 • 2.8 
4,0 • 2.5 
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TABLE III. GTG lesion «lie in alpha-m«khylp#r#tyro#in* (ANPT) craatad 
and control ntiee 
Traatflwnt n Laaion sis» 
(man • SO) 
(cmf; 746) 
Control U 5.9 ^  1.9 
AMPT 15 11.5 • 3.9* 





CBAPTER 7. THE EFFECT OF ESTRADIOL BENZOATE ON GOLD 
THIOCLUCOSE NECROSIS IN THE VENTROMEDIAL HYPOTHALAMUS 
Introduction 
Eftrogen (EST) e«n influence aeveral a#p#ct# of carbohydrate 
netabolian including gluconeogeneai#, glycogen synthesis, and blood 
glucose levels (Wade and Gray, 1979). Glucose uptake in muscle (HcKerns 
et al., 1958) and adipose tissue (Cilmour and NcKerns, 1966) are 
enhanced EST. This cellular uptake of glucose may be due to the 
estrogenic stimulation of insulin secretion from the islets (Costrini 
and Kalkhoff, 1971* Wade and Gray. 1979). Moreover, tissues apparently 
are supersensitized to insulin by EST (King and Co%, 1973), consequently 
increasing glucose metabolism (Wade and Gray, 1979). 
In addition to affecting carbohydrate metabolism, EST can alter 
food intake and body weight (Fishman, 1976; Wade and Cray, 1979). A» 
EST levels increase during the ovulatory cycle, food intake and body 
weight decrease (Fishman, 1976). Ovariectomised (OVX) animals do not 
exhibit these decreases. Replacement therapy for OVX animals with EST 
or EST analogs produces a reduction in food intake and weight (Fishman, 
1976; Wade and Cray, 1979). It is noteworthy that EST apparently 
decreases body weight only by altering carWhydrate intake (Wurtman and 
Baum, 1980). 
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Th# exact iMChanisn of EST action on food intake is unknown, but 
may involve tha ventronadial hypothalamus (VMM). Implants of EST 
directly into the VMM suppress food intake (Jankowiak and Stern, 1974). 
When surrounding nuclei received EST implants, no changes in feeding 
behavior were observed. This result was expected since the VIQf has a 
high affinity for EST, while adjacent areas do not (Jankowiak and Stern, 
1974). 
The VIM also is affected by the drug gold thioglucose (CTC). A 
single intraperitoneal injection of CTC cauaes a specific lesion in the 
VMM, followed by a chronic hyperphagia and obesity (Marshall et al., 
19)5). Oebona et al* (1979b) have demonstrated that CTC is highly 
specific for neural tissue in the VMM and that CTC lesion formation is 
dependent on the presence of insulin in the VMM (Debons et al., 196#; 
1969; 1970). An intrahypothalamic injection of insulin caused a return 
of CTC sensitivity in the VMM of diabetic animals* Although insulin 
apparently does not affect glucose oxidation in the brain in vivo or in 
vitro (Coodner and Berrie, 1977; Brown and Viles, 1980), this hormone is 
present in kW brain (Hsvrankova et al., 1978b)* Recently, CTG-induced 
VMM necrosis has been shown to be sensitive to EST. Youi% et al. (1978) 
demonstrated that EST administration increased significantly the size of 
CTC lesions. These authors suggested that glucose uptake and/or storage 
may be enhanced in the VMM by EST. 
Since EST can facilitate glucose uptake and enhance insulin effects 
in various tissues (Wade and Gray, 1979), treatment of diabetic animals 
with EST mi^t cause a reversal of VMM insensitivity to CTC necrosis. 
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In order to examine the possible effects of EST on VMH glucose oxidation 
in a more quantitative fashion, in vitro incubations using glucose 
were performed. 
Materials and Methods 
Cn female o^cc» weighing 20-25 gn were used in this study. The 
animals were maintained at 23*C on a 12 hour light<12 hour dark 
photoperiod» fed Teklad Rat and Mouse Diet, and given tap water freely. 
Mice were made diabetic bf a single intravenous injection of alloxan, a 
300 mg/kg dose in a 3S aqueous solution* Mice were judged diabetic and 
used for experimentation if glucoauria was evident using a Clinistix, 
three days after alloxan adWnistration. A pharmacological dose of 
estradiol bensoate (SB), an EST analog, in oil (10 ug per nwuse per day) 
or oil alone was injected subcutaneously for 4 days, beginning on the 
day of the alloxan injection. Once diabetes was established on the 
third day after alloxan aAwinistration, the mice were challenged with a 
300 mg/kg CTC dose. The animals were decapitated 24 hours later. The 
brains were removed from the skull and fixed in Bouin's fluid for 
4# hours* The brains were dehydrated, embedded in paraffin, sectioned 
at 7 iM, mounted on glass slides, stained with hematoxylin and eosin, 
and the VWI examined for CTC-induced pathology by light microscopy. 
The procedure for the in vitro VMH glucose oxidation studies has 
been described previously (Brown and Viles, 1980; 1982). Briefly, 
culture vessels with Vlfii tissue in medium were supplemented with 1 or 
3 ug of EB in 15 ul of ethanol, resulting in 0.67 and 2.0 mM of EB 
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respectively in the culture medium. Control vessels received ethanol 
only. Tissue incubated with dinitrophenol served as an indicator for 
tissue viability, as described earlier (Brown and Viles, 1980; 1982). 
The t test was used for determining statistical significance. 
Results 
Diabetic controls given oil alone and CTG did not display any 
lesion formation (Figure 1). Diabetic mice given EB in oil and 
challenged with did not develop lesions in the VMM (figure 1). CB, 
therefore, did not reverse the inhibition of GTG-induced lesion 
formation caused by an absence of insulin in diabetic Wee, EB (1 ug or 
3 ug in ethanol) had no significant effect on glucose oxidation in VtOt 
caps compared to controls suppleownted with ethanol alone (figure 2), 
Since ethanol may have an acute affect on glucose oxidation, the 
controls with ethaiwl were compared with a control group supplemented 
with saline instead of ethanol. Ethanol depressed glucose oxidation 
significantly (p<0.00l) (figure 2). The studies of Brown and Viles 
(1980; 1982) confirmed that the hypothalamic tissue was viable during 
experimentation. Empirically, these dinitrophenol results were 
confirmed in this study. 
Discussion 
Diabetic mice do not develop GtG lesions because lesion formation 
is insulin-dependent (Debons et si., 1968; 1969; 1970), Since EST is 
known to supersensitize tissue to insulin (Kii% and Cox, 1973) and 
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enhance CTO lesion formation in the VNH (Young et al., 1978), we 
postulated that EST night cause a return of GTG sensitivity in the VMM 
of diabetic Wee, onich in the same manner that adrenalectomy reverses 
GTG insensitivity in diabetics (Debons et al., 1974; 1977). However, EB 
supplements given to diabetic mice had m» effect on GTG lesion 
formation. Apparently, EST is not effective in reversing the diabetic 
block to cm lesion development in the VMM. Although EST is known to 
have an influence on carbohydrate metabolism (Wade and Cray, 1979), this 
effect is probably not significant compared to aberration* in 
carbohydrate metabolism associated with diabetes. 
Glucose oxidation in vitro was measured to determine if EST does 
affect VMH glucose metabolism. EB had no apparent effect on glucose 
oxidation in the VNH. This result suggests that EST does not have a 
significant effect on VNH glucose transport and utilization. However, 
ethanol was the solvent for EB and may have interfered with glucose 
oxidation. Alcohol administration can alter glucose transport and 
metabolism in the small intestine, liver, heart, and brain (Roe, 1979). 
Specifically, Towell and Erwin (1982) have shown that ethanol treatment 
in the isolated perfused mouse brain at 37*C decreased the glucose 
utilisation rate in the hypothalamus significantly. Our ethanol 
controls confirmed this finding; these vessels exhibited over a 62% 
decrease in glucose oxidation as measured by CO^ evolution. Thus, 
any EB effects in this in vitro system may have been masked by the 
alcohol solvent. 
Figure 1, The effect of eetrsdiol benioete (EB) treatment on GTG legion 
formation in the VHH of alloxan-diabetic i^ee. A. Control. 
Diabetic mice given oil alone and GTG. No leaion i# apparent 
in the VKH. B. A (ttabetic mouse given EB in oil and 
challenged with GTG. No necrosis of the can be discerned 
% 
- c 
Figure 2. Tba offeet of «thcnol or othsiMl «nd estradiol benxoate O) 
on glucose oxidation in the «ouse VKH. Saline controls 
oxidised significantly more glucose compared with each 


































CNAPm 8. STRESS INHIBITS COLD THIOCUICOSE-fNOUCEO 
HYRynrALANIC DAMAGE 
Introduction 
Cold thioflueca* (GTG) i# kiwwn to induce hyp#rph#gi# coupled with 
destruction of the ventromedial hypothelemis (VKH) (Debons et al., 
1977). This sensitivity of the VMN to GTC is altered by the presence or 
absence of various hormones. For instance, insulin was necessary for 
development of GTG necrosis in the VNH» since diabetic animals are 
insensitive to a GTG chollei^e (Debons et al., 1968s 1969; 1970). 
Glucocorticoid administration abolished GTG necrosis in the Vm (Debons 
et al., 1977; Brown, 1982a). In addition, mice that were insensitive to 
a GÎC challenge due to diabetes mellitus became vulnerable to the drug 
after adrenalectoiay (ADX) (Debons et al., 1974b), Injections of 
estradiol bemoate »uper-sen»itized the VKB to CTC-induced damage (Young 
et al., 1978). 
Caffyn (1971;1972@ and b) end Liebelt and Perry (1967) have 
suggested that is a nonspecific hypothalamic vascular toxin. 
Allegedly capillary breakdown, edema and ischemia, caused by GTG 
administration, resulted in VHB lesion development (Caffyn, 1971; 1972a 
and b). However, this evideiuie has been questioned recently (Young et 
al., 1979; Debons et al., 1979b). Debons and colleagues (1979b) have 
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shown, by ultrastructural studies, that GTG necrosis is very specific. 
The initial pathology is limited to an area between the arcuate and VNH 
nuclei. Debons et al. (1979b) concluded GTG necrosis is specific for 
neural components in the VMH. 
furtheriwre, the neurotransmitter serotonin (SBT) has been 
suggested to be the mediator of GTG necrosis in the (Debons et al., 
1979a). Depletion of 3^ stores with para-chloro-phenylalanine, 
reserpine or antagonism of SHT action with cyproheptadine, methylsergide 
or chlorpromaiine, all prevented GTG lesion formation (Debons et al., 
1979a: Briese and Murmi, 1981). However, 24 hours after drug treatment, 
wiMn 39T levels are still low, mice challenged with GTG develop typical 
VNH lesions. Apparently this phenomenon is caused by a return of 
tryptophan (TRP) hydroxylase activity for the production of SUT. 
Stress can lead to alterations in systemic (Asmitia and NcEwen, 
1974) and brain (Kakihana and Moore, 1978) glucocorticoid concentration* 
and 3BT metabolism (Tuwiler, 1979), Moreover, these alterations in 
glucocorticoid and 5HT activity stress may not be independent effect» 
of the stress, Fa#tix%, cold exposure, restraint, ether anesthesia, 
alcohol adninistration, frustration, formalin injections, novelty, 
trauma and electric foot shock all increase glucocorticoid 
concentrations in the plasma and brain (Boulouard, 1963; Kakihana and 
Moore, 1978; Yuwiler, 1979), Electric foot shock, ether anesthesia and 
cold exposure also increase TRP hydroxylase activity (Azmitia and 
McEwen, 1974). Glucocorticoid administration alone, to normal 
experimental animals, will increase TRP hydroxylase activity (Azimtia 
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•lut NcEwttfi, 1974), Chtt rat* limiting cnsyna in SHT synthesis, while ADX 
blocks the stress-induced increase in TRP hydroxylase activity (Ste et 
al., 1976). Other investigators (Palkovita et al., 1976; Ste et al., 
1976) have shown that stress does not alter TUP hydroxylase activity but 
lowers 5NT concentrations by causing an increased turnover rate of 5*1. 
Xn addition, recent reports support the idea that increased SVT levels 
parallel increased glucocorticoid concentrations in the body (NcEwen, 
1980). These studies indicate that stress can alter SHT metabolism. 
As reviewed above, stress can alter glucocorticoid levels and 5WT 
synthesis, compounds which are known to play a role in CTC lesion 
formation* Xn this atudy, we investigated the effect of two stress 
syndromes, cold exposure and food deprivation (starvation), on CTC-
induced necrosis in ttw mouse VM*. In addition, the effect of TRP 
supplements on CTC lesion development during the starvation syndrome was 
tested. 
Material* and Methods 
CFl female mice, weighing between 20-25 gm were u*ed in this study. 
The animal* were hou*«d at 23^C with a 12 hour light;12 hour dark 
photoperiod, fed Teklad Rat and Mouse Diet and given tap water freely. 
Unless stated otherwise, GTG ws* given intraperifconeally (IP) in a 
300 mg/kg dose. Cold stress consisted of a 29 hour exposure at 4®C in a 
cold room. GTG was administered 5 hours after the beginning of the cold 
exposure period. Mice deprived of food were fasted 72 hoars before GTC 
was injected. Controls for the cold stress or fasted experiments were 
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maintained at 23% and fad lab chow ad lib, rampactively. 
Bilateral ADX*s were done on «tlce under metafane anesthesia. The 
animals were allowed to recover 1-3 days before being subjected to the 
stress of food deprivation and challenged with CTG. All AOX mice were 
given 0,9% saline instead of tap water to compensate for the loss of the 
mineralcorticoids. 
In separate experiments TUP was given to food deprived animals. In 
the first study, i^ce were starved for 3 days. On the third day, TRP 
(400 mg/kg) was administered IP two times, once two hours before CTG 
(200 mg/Wg IP) and again 5 hours after GIG. The brains from these 
animals were examined for lesions but not processed for photographic 
purposes. In another study* TRP (100 mg/kg IP) was injected into mice 2 
or 3 times a day at 4 to 8 hour intervals over k days of starvation. On 
the third day following removal of the food supply, the mice were 
challenged with CTG (300 mg/kg). The VW of these animals was examined 
for neural damage but not photographed. 
Animals were decapitated 24 hours post (îTC injection. The brains 
were reMved fro# the skull and the VMB was dissected free as a cube of 
tissue and fixed overnight in 10% formalin. These tissues were e«*edded 
in 8% agar and sectioned at 50u using a Smith and Farquhar tissue 
sectioner. GTC-induced pathology of the VMM was rapidly determined in 
these sections using the Penfield modification of the del Rio Borcega 
silver carbonate reaction for oligodendroglia (Humason, 1972) and light 
microscopy. For photographic purposes, brains from the food deprived, 
cold exposed mice and controls challenged with CTG were fixed in Bouin's 
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fluid» dehydrated, embedded in paraffin, sectioned at 7u», stained with 
hematoxylin and eosin, and photographed using a light microscope. 
Results 
CTC necrosis was inhibited in animals subjected to food deprivation 
(Figure 1) or cold exposure (Figure 2), The VHM of these stressed 
animals challenged with CTO was indistinguishable from normal untreated 
mice. Control animals, fed and maintained at 23%, developed typical 
VMM lesions when challenged with (ïTC. Inhibition of CTC lesion 
formation in stressed animals was always complete and consistent (Table 
IK 
Preliminary data from AD% mice that were starved showed no lesion 
formation when given CTC. The vm from these animals was 
indistinguishable from the starved mice given <^G. Apparently removal 
of removal of glucocorticoids had no effect on VNH insensitlvity to CTC 
during starvation, 
TRP administration had no effect on lesion formation during food 
deprivation. Animals given the two 4(X) mg/kg TRP injections (IF) at a 7 
hour interval after 3 days of starvation and challenged with 200 mg/kg 
(ZfC Z hours after the first TRP injection, exhibited no CTC^indueed 
necrosis in the VMM (Table II). When TRP (l(X) mg/kg IP) was given Z or 
3 times a day at 4 to 8 hour interval* for 4 days during starvation, and 
the animals then challenged with CTC (300 mg/fcg IP) on the third day, 




Sine# injoctlons of cortisono or hydrocortisone are known to cause 
inhibition of CTG lesion development in the VMH (Debons et si., 1977t 
Brown, 1982a), it is tenable that environmental and physiological 
conditions which elevate glucocorticoid concentrations in the plasma may 
also alter the VMM response to GTG. Stress elevates glucocorticoid 
levels in the blood and brain (Kakihana and Moore, 1978), and might 
insensitiie the VMS to a CTC challenge* Caffyn (1972b) has suggested 
that CTC necrosis in the VMB is the result of a vascular inflammatory 
response. This work suggested that glucocorticoids, as well as other 
anti-inflammatory drugs such as aspirin, could abolish CTC-induced 
pathology by preventing the inflammatory response in the VMM. However. 
Debons et al. (1974b) have shown that cortisone, in amounts insufficient 
to prevent CTC necrosis in normal animals, can abolish CTC lesion 
formation in diabetic-ADX (Umg-Lukens) animals. Moreover, 
ultrastructural evidence has Wen reported indicating that the primary 
site of CTC action is neural and not vascular (Debons et al., 1979b). 
Glucocorticoid injections increase TRP l^droxylase activity in the 
brain (Asimtia and McEwen, 1974), while AOX inhibits the acceleration of 
TRP metabolism observed with glucocorticoid administration or stress . 
(Sze et al., 1976). Since CTG lesion development appears to be 
dependent on the VMH SMT and TRP hydroxylase activity (Debons et al., 
1979a), it might be expected that glucocorticoid injections would 
enhance CTC-induced damage in the VI#. However, it is well known that 
glucocorticoid treatment prevents &CC lesion formation (Debons et al.. 
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1977; Brown, 1982a). Palkovits «t al. (1976) and Sz« at al. <1976) have 
damonatratcd daeraasad concantration* of brain 5NT, umlar strata 
conditions. Thay postulatad that an incraasa in 3HT turnover rate 
yielded decreased SUT pools. These lowered SKT stores, due to the high 
turnover rate of 5MT, could explain the desensitising effect 
glucocorticoids and stress have on the amuse VKH when challenged with 
CTC. 
Our data show that CTC-induced necrosis in the VMH is eliminated by 
the imposition of stress. No CTC lesions were detected in mice 
subjected to cold exposure or food deprivation. This result is 
consistent with reports made in the literature (Debons et al., 1977; 
Brown, l9S2a). As described above, CTC lesion formation is dependent on 
the activity of TRP hydroxylase and probably 5NT content in the vm. 
Although stress increases glucocorticoid levels, thereby increasing TRP 
hydroxylase activity, the tremendous turnover rate of 5HT that results 
fro# the glucocorticoid stimulation may actually decrease the pool size 
of iWf in the VMM (Eccleston and Nicolaou, 1978). Thus, CTC lesion 
formation would be eliminated by stress. Another possibility is that 
glucocorticoids may bind to cells in the vm and block CfC necrosis 
directly (Kakihana and Moore, 1978; Brown, 1982a), 
Diet is known to affect the levels of neurotransmitters in the 
brain (Wurtman and Fernstrom, 1974). Since 5BT is implicated as a 
mediator of CTC lesion formation, TRP was injected into starved mice. 
It was anticipated that if 58? is a major factor in the development of 
CTC necrosis in the VMH, administration of TRP would increase the TRP 
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hydroxylase activity and 5HT level in the VMM and perhaps reverse the 
inhibition of CÎG lesion formation during stress. As the results 
indicate, TRP treatment during starvation did not sensitize the VMM to a 
CTC challenge. This evidence suggests that SlfT concentrations and TRP 
hydroxylase activity, although important in the mediation of CtC-induced 
damage in the VMS, may be of secondary importance to the glucocorticoid 
status in the animal. Apparently increases in glucocorticoid levels in 
the blood and brain will counteract any effect a 5HT metabolism change 
will have on CTC lesion formation. 
Durii^ starvation, removal of the adrenal gland will cause a 
significant decrease in the blood glucocorticoid levels and perhaps 
sensitise the VNH to CTC during starvation. However, our preliminary 
data indicate that AD% and food deprived mice do not develop VMH 
lesions, when challenged with CTC. Two alternatives may have caused 
this result in the AD%-#t#rved mice. During starvation, ketone bodies 
are the main energy source for the brain. Young et al. (1979) have 
suggested that CTC vulnerability of the V*# is associated with glucose 
utilisation in the area. With little glucoae available to the 
hypothalamus, CTC lesion formation may be eliminated. Thus, the VMH of 
stressed and AOX mice, utilising ketone bodies mainly for energy, would 
not be susceptable to CTC necrosis. On the other hand, the AOX may have 
been incomplete. In this case, the mice would not develop a 
glucocorticoid deficiency. In addition, auxiliary adrenal-like bodies 
are known to exist in mice (Soffer, 1956). This tissue may have 
compensated for the glucocorticoid loss due to AOX. 
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Another atpcet of GTC lesion formation, that must be considered 
during periods of food deprivation» is the insulin requirement. It has 
been demonstrated that during starvation, insulin blood levels are 
significantly reduced (Dubuc et al., 1982). Interestingly, insulin 
deficient mice do not develop VMi lesions when challenged with CTG 
(Debons et al., 1968* 1969* 1970). This lowered insulin concentration 
in the body may contribute to inhibition of GTC lesion formation. 
Although this possibility i* tenable, it is probably unlikely. 
Starvation does not abolish insulin secretion. Adrenalectomy will 
reverse GTC insensitivity in diabetic atice even though insulin levels 
are undetectable. The glucocorticoids apparently play a major role in 
CTC lecion formation (Oebons et al., 1982; Brown, I982a>. 
Recently, u#ii% abdominal irritation, induced with carrageenan in 
mice, GTC lecion formation was inhibited during this stress (Brown, 
1982b). Controls diaplayed typical bilateral lesions in the VW* from 
GTC adfl^niStration. Immediately before the GTC injection, a tail vein 
blood sample was taken and the corticosterone concentration measured by 
rodioimmunoassy, in both control and experimental animals. Systemic 
corticosterone levels were si|y*ificantly elevated over controls. This 
evidence suggests that increases in glucocorticoid levels following 
stress inhibit CÎC lesion formation. 
In conclusion, this report indicates that stress, due to food 
deprivation or cold exposure, will prevent GTC lesion formation in the 
mouse VHH, probably by elevating systemic glucocorticoid levels. TRP 
loading had no effect on seositizi% the VMB to GIC in starved otice. 
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Apparently, the glucocorticoid status of the animal is of utmost 
importance for GTC lesion development, while 5HT changes during 
starvation apparently are of little consequence. 
Figur* 1. Crosf-fcetionf of the VMH at the level of the mdian eminence 
froa ediee challenged with GÎC. A. A oMuae deprived of food 
for 3 day# and then given GTC. B. Control—a mowme fed ad 
lib and edminiatered GTG 
U6 
figure 2. Crosi-iaction» of the VKH «t the median eminence level from 
fKice challenged with GÎC. A. A mouse maintained at 4% for 
29 hour». CTC waa given 5 hours after the cold exposure 
began. B. Control. A mouse maintained at room temperature 
(23*0 and given CTC 
119 
119 
TABLE 1. The effect of fasting and cold exposure on CTG-induced 
necrosis in the VMN 
Stress Treatment n VHR necrosis 
(% incidence) 
fasted 
Control # CTC 12 100 
fasted • CTC 1) 0 
Cold exposure 
Control + CTC 






TABLE 11. The effect of tryptophan (TRP) given 3 days after starvation 
on CTG lesion formation 
Treatment n Incidence of 
Necrosis 
(S) 
Starved • + CTG 7 0 
Starved * TRP * GTC 8 0 
red + lljO • GTC 7 100 
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TABLE 111. The effect of tryptophan (TRP) given to mice during 
starvation on CTC lesion formation 
Treatment n Incidence of 
Necrosis 
(%) 
Starved with WgO; GtC 
Starved with TRP; GTG 









ULTRASTRUCTURE Of GTC LESION FORMATION 
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CHAPTER 9. AN ULTRASTRUCTURAL STUDY OF COLD THIOCLUCOSE 
LESION FORMATION IN THE VENTROMEDIAL HYPOTHALAMUS. 
X. SUBNECROTIC COLD THIOCLUCOSE DOSE 
Introduction 
A single intraperitoneal injection of gold thioglucose (CTC) in 
mice causes hyperphagia and eventual obesity (Brecher and Waxier, 1949). 
This obesity syndrome induced by CTC has been attributed to the 
destruction of the ventromedial hypothalamus (VHH) by CTC (Marshall et 
al.* 1955), 
The idea that gold thioglucose ((TTC) is a vascular toxin to 
capillaries in the ventroowdial hypothalamus (VMS) has enjoyed 
widespread acceptance# Liebelt and Perry (1967) reasoned that since 
extrahypothalamic stuuctures appeared damaged by (TTC, the destruction 
was non-specific, Caffyn (1971) added ultrastructural evidence to this 
postulate. The capillary endothelium appeared disruped in the early 
development of CTC-induced lesions in the VMS. Furthermore, Levine and 
Sowinski (1982; 1983; also Nochlin and Levine, 1982) have reported the 
triamine, 3,3'-methylimino-bi@-(N-methylpropylamine) (MIMPA), produced 
nearly identical hypothalamic lesions as those lesions induced in the 
VMH by a CTG challenge. These authors surmized that since MIMPA and CTC 
lesions cause similar VHH destruction, these very different compounds 
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indue* VNB lesions by a comaon non-spsciCic action, namely breakdown of 
the hypothalamic microvasculature. 
However* Young et al. (1979) have noted that the median emiiMfKe» 
an area with a weak blood-brain barrier, is not vulnerable to CTC 
necrosis, suggesting GTG is not a general vascular or neural toxin. 
Interestingly, ÏKMPA injections also do not damage the median eminence 
(Nochlin and Levine, 1962). Debons and his colleagues (1977; 1979b) 
have demonstrated, using a subnecrotic or microlesion dose of (*tC (100 
mg/kg), that the capillary structure in the VMM was not destroyed by 
GIK*. Instead the perivascular neuropil was clearly damaged. 
The ultrastructural studies done by Caffyn (1971; 19728 and b) and 
Debons et al. (1977; 1979b) present conflicting interpretations with 
respect to (*tC action in the VMM. Additional electron microscopic 
examination could reduce the apparent divergence in these two studies. 
In this paper, we have examined sequentially the ultrastructural 
develo^sent of <*ÎC microlesions (VMM necrosis not visible at the light 
microscope level) in the mouse VMM, 
Materials and Methods 
female CFl mice, weighing 20-25 gm were used in this study. The 
mice were maintained at 23®C, on a 12 hour light:12 hour dark 
photoperiod, fed Teklad Rat and Mouse Diet and given tap water freely. 
Groups of 5 mice each were administered 100 mg/kg (RG 
intraperitoneally (IP) and sacrificed 4, 8, or 24 hours after injection. 
Controls (n-5) received water IP, All mice were perfused with 5% 
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glutcraldohydc in 0.1 M phosphats buffer (Sorenton), adjusted to pH 7.4, 
for 3 minutes at a flow rate of 1 ml/15 seconds. Following perfusion, 
the brain was removed from the skull and the VMM removed as a cube of 
tissue. This cube was placed in it gluteraldehyde overnight. Following 
washes in 0.2 M phosphate buffer with 4% sucrose, the tissue cube was 
embedded in 8Z agar and sectioned coronally at 100 un« using a Smith and 
Farquhar tissue sectioner. The section containing the cell poor area, 
described by Debons et al. (1979b) as the origin of CTC-induced 
pathology» was located with a dissecting microscope, utilising the 
median eminence as a marker. This section was processed for electron 
microscopy. The section was post fixed for 1 hour with 12 osmium 
tetroxide in a vernal-acetate buffer with 1.5% potassium ftrricyanide to 
enhance contrast (Langford and Coggeshall, 1979). following washes in 
vernal-acetate buffer with 4% sucrose, the tissue was stained en bloc 
with uranyl acetate (Hayat, 1975), in vernal-acetate buffer for 2 hour#. 
After additional washes in vernal-acetate buffer with sucrose, and 
dehydration in ethanol to acetone, the section was allowed to stand in a 
mixture of acetone and Spurr's epoxy ovenxig^t under vacuum. The 
section was then placed in Spurr's medium overnight and under vactmm. 
Curing of the block was accomplished over the next 24 hours in a 60*C 
oven. Silver sections (90 tm thick) were obtained by using a Sugg 
diamond knife and 1KB Buxley ultramicroeome. The sections were picked 
up on clean 200 mesh grids, stained with IZ lead citrate (Venable and 
Coggeshall, 1965), and examined with a Hitachi ll-E electron microscope, 
operated at SO KV with a SO um objective aperture. 
126 
Results 
Normal VMM tissue 
Tissue located in the cell poor area Wtween the arcuate and VMM 
nucleit corresponding to the site of origin of the GTG lesion, was 
examined. The region was characterised by a well developed 
microvasculature, densely packed cell processes of several sises, 
myelinated axons, many synapses and a few cell bodies (Figure 1). The 
capillaries exhibited characteristic structure with the lumen surrounded 
by endothelial cells and associated basement lamina. Distal to and 
surrounding the basement lamina were flattened cell processes similar to 
astrocytic end feet Surrounding this complex was an array of cell 
processes of several sizes and types, tightly packed together with iw 
extracellular spaces. The small processes were organized in discrete 
bundles interspersed among large processes. The large processes 
contained microtubules, mitochondria, cisternae of the endoplasmic 
reticulum, and plasmslemmal surface men^ranea. The cell bodies were 
large, nucleated and contained am array of mit%hondria, cisternae of 
the endoplasmic reticulum, and golgi complexes. A large nwAer of 
synapses were observed with characteristic synaptic vesicles and 
synaptic junctions. These were most frequently located between apposed 
large processes. Myelinated axons were scattered throughout the mass of 
cell processes. 
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100 Bft/kg CTG 
4 hour» post injection At four hours after injection with 100 
ng/ttg ore, the cell poor area, which is the site of origin of the 
lesion, exhibited minimal structural changes from the normal, control 
tissue samples (Figure 2). Patches of cytoplasm of son* of the large 
processes was electron lucid. Accumulation of membranous vacuoles and 
an absence of microtubules were characteristically observed in the large 
lucid processes. The mitochondria, however, were not swollen and showed 
no structural changes when compared to the normal, control condition. 
Synapses Joinii^ the large, lucid processes were not disrupted. 
Capillaries and myelinated fibers appeared normal. 
8 hours post injection At 8 hours after injection with a 
microlesion dose of GtC, distinctive changes were observed in the region 
of lesion origin (Figure 3). The mierovasculature apfwared identical to 
the normal, control tissue. However, in the pericapillary areas 
cellular processes adjacent to the basement lamina were electron lucid. 
Cytoplasmic organelles except mitochondria were absent and a few 
membranous vacuoles were distributed throu^iout the membrane Imund luci4 
area. The plasmalemmal surface membranes bounding these area* exhibited 
no structural discontinuities, although there was swse apparent 
swelling. Other areas in the adjacent neuropil also were observed to be 
electron lucid. These areas were located adjacent to nearby large 
processes and the other surrounding cellular components. These apparent 
spaces, however, were bounded by plasmaleamal membranes and contained 
recognizable mitochondria as well as membranous vacuoles. 
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Large processes in the pericapillary area occasionally exhibited 
loss of electron density and the presence of membranous vacuoles. In 
addition, some iritochondrial profiles exhibited swelling or distention. 
These processes always contained microtubules. Interestingly, profiles 
of the electron lucid large processes were usually found adjacent to the 
other electron lucid processes in the neuropil. Synapses observed in 
the area occasionally exhibited some swelling, however, the synaptic 
junctions remained intact. 
24 twurs post injection At 24 hours after injection with a 
microlesion dose of GTG, pronounced structural changes were observed in 
the cell poor region where the lesion originated (Figures 4A and B). 
These changes involved the cellular elements surrounding the 
microvasculature. The capillary endothelium at 24 hours was identical 
to the capillary endothelium in the normal, control tissue. There were 
no structural discontinuities in the endothelial cells and desmosomes 
and tight junctions were not separated or disrupted. Immediately 
adjacent to the capillary basement lamina, electron dense, membrane 
Iwmnd spaces were observed. These spaces contained membrane bound 
vacuoles, punctate electron dense particles, and occasional 
mitochondria. Areas of the neuropil also contained profiles simdlar to 
the pericapillary spaces. These electron lucid areas were bounded by 
plasmalemmal membranes with membranous vacuole» and electron dense 
particles, and occasional mitochondria. Areas of the neuropil also 
contained profiles similar to the pericapillary spaces. These electron 
lucid areas were bounded by plasmalemmal membranes with membranous 
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vacuole* end electron dense particles in the lumen of the spaces. The 
electron lucid spaces were interdigitated among the large and small 
processes in the neuropil. Many of the large processes were also 
electron lucid and contained membranous vacuoles. The synaptic 
JufKtions, however, remained intact. In sonw cases, the cell bodies 
contained swollen vacuolated structures, extremely dark cytoplasm and 
occasional darkly stained inclusion bodies distributed through extremely 
electron dense cytoplasm. Myelinated axons, on the other hand, were 
identical to those seen in normal, control tissue. 
Discussion 
GTC has been proposed to cause VMM lesions and subsequent changes 
in feeding in behavior by acting as a vascular toxin, which alters 
capillary permeability, leading to ischemia and subsequent tissue 
destruction in the lesion area (Caffyn, 1971{ 1972a and bt Liebelt and 
Perry, 1967t Levine and Sowinski, 1982; 1983; Nochlin and Levine, 1982). 
Using a necrotic dose (macrolesion) of GTC, Caffyn (1971) reported 
that the microvaaeulature of the VMB was damaged by GTC. She described 
capillary breakdown and edema, which destroyed the adjacent neuropil. 
Early during GTC leaioo development, Caffyn (1971) described swollen 
processes around the capillary in the neuropil. Presumably these 
structures were dendrites or astrocytic end feet. Longer periods after 
the GTC Ghalle%e, neuronal destruction developed with extensive 
distention of a large area. Debons et al. (1977; 1977b), on the other 
hand, have described the pericapillary changes in the VMB during 
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nicrolosion formation following a subnacrotic dose of GTC. Thcsa 
authors reported fra^Mntation and dissolution of th# neuropil in the 
area surrounding the capillaries. No vasuclar destruction was detected. 
In this study tissue from the cell poor region between the arcuate 
nucleus and the VMH was examined 4 hours after injection with a 
microlesion dose of GTG. this tissue was essentially identical to 
tissue from the small area in normal, control animals. Eight hours 
after injection with (TTC, pronounced changes were observed in the 
pericapillary areas corresponding to astrocytic end feet and adjacent 
large processes. The striking loss of electron density in the cytoplasm 
and accumulation of membranous vacuolea suggests degeneration of the 
cytoplasm and some of the membranous organelles. This apparent 
cytoplasmic degeneration is even more pronounced in the pericapillary 
areas and adjacent large processes in the 24 hours post injection 
samples. In addition, at 24 hours degenerative changes were seen in 
some cell bodies and synaptic terminals. 
Significantly, our finding do not indicate any observable damage to 
the capillaries in the cell poor region between the arcuate and V#W. 24 
hours after injection with a microlesion dose of CTC. Rather 
pericapillary elements, either astrocytic end feet or dendrites, 
exhibited loss of membrawus organelles and loss of electron density, 
similar to the cytoplasmic dissolution that has been reported by Debons 
et al. (1977; 1979b). Some large cellular processes in the surroundi*% 
neuropil also exhibited similar changes, suggesting that axonal 
processes may also be damaged. Occasionally, cell bodies adjacent to 
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damaged proc«as«s exhibited an increased electron density, which may be 
indicative of damage. 
Caffyn (1971) has suggested that hypothalamic damage produced by 
GTC could aerve as another experimental model for cerebral edema 
studies. Whereas it is difficult to estimate changes in capillary 
permeability by observation, structural evidence of edema that might 
result is more easily determined. Techniques used to include cerebral 
edema, such as trauma to the brain, diptheria toxin injection, cerebral 
compression, sinus obstruction or jugular ligation, all produced edema 
with miniflMl vascular distortion (Wechsler 1967). After development of 
edema, the affected area became necrotic, involvii^ damage to both 
neuronal and glial cells. The neuronal degeneration follow!^ 
experimentally induced edema reported by Wechsler (1967) strongly 
resembled the neuronal damage reported in this study. A search for 
structural manifestation of edema during microlesion development 
revealed no extracellular spaces that could be attributed to edematous 
swelling, rather the damaged processes noted above were distended or 
swollen. Despite loss of cytoplasmic density and cytoplasmic membranous 
organelles, the plasmalemsal surface membranes were intact with no 
structural discontinuities. There was no evidence of fragmentation of 
cells or accuBMlations of cellular debris in the microlesion area. The 
capillaries and surrounding neuropil had not been disrupted and areas of 
the VMM nearby the GTG-induced microlesion appeared normal. 
Definitive VHH damage was not readily identifiable until 8 hours 
after the lOO mg/kg GTG injection. At 8 hours and later, pericapillary 
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changes were evident. Large fibers showed distention of the cytoplasm 
and loss of cytoplasmic density. GTC-induced changes involving large 
processes also were evident in areas not directly associated with 
capillaries, however, smaller fibers in the neuropil appeared undamaged. 
In all instances, the capillary endothelium was mrmal. 
At 24 hours post CtC injection, more extensive damage was evident. 
Large perivascular and non-perivascular processes displayed almost 
complete cytoplasmic dissolution with little debris. Degenerating cell 
tKKties were present and synaptic Junctions end swollen synaptic boutons 
were associated with these cells. 
The large neuronal processes appeared to be the main VMM component 
affected by CTC administration in eubnecrotic doses. Small processes in 
the neuropil, as well as myelinated processes, were apparently 
undamaged. The damaged processes might be dendrites. However, tfechsler 
(1967) determined that the initial swelling in other model systems 
involving induction of edema occurred in astrocytic processes. These 
swollen processes were nearly identical to those we found. However, 
close examination of the large processes in our micrographs revealed the 
present of microtubule* and tubular smooth endoplasmic reticulum, 
indicative of dendrites (RWdin, 1974). In addition, it is evident that 
synapses were formed with these large processes. Moreover, the large 
degenera&ing cell bodies seen 24 hours after administration of a 
microlesion dose of CTG are neurons. Definitive synaptic complexes were 
visible on these electron dense cells. It is conceivable that 
degeneration of these neurons began at the dendritic level. Based on 
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thia information, the VMM structures affected initially by a subnecrotic 
dose of (*TG, are neuronal, as opposed to glial. 
Our findings that neural rather than vascular components in the V# 
are affectd by CTC are consistent with the reports made by Debons et al. 
(1977* 1979b), The hypotheses of Liebelt and Perry (1967), Caffyn 
(1971) and Levine and Sowinski (1982; 1983; also see Nochlin and Levin, 
1982) need to be reexamined, CTC may not be vascular toxin, inducing 
edema and ischemia in the hypothalamus and eventually neural necrosis. 
The evideiKe presented here indicates that (îTC is a specific nervous 
tissue poison for the VHH. With such a high specificity for the 
hypothalamus, CTC could be used as an experimental, pharmacological 
probe for hypothalamic fumrtion (Caffyn 1971; Debons et al,, 1979b). 
Figure 1. A •«ceion from tho VMM of an untreated muse, illustrating 
normal and intact perivascular neuropil. Uranyl acetate and 
lead citrate stains. Magnification 7400x 
13? 
Figure 2. A VMH lection from » movme treated with 100 mg/kg CTC and 
Mcrifieed 4 hours po#t injection. Little change is observed 
in this tissue compared with normal VMH. Uranyl acetate and 
lead citrate stains. Magnification 7400* 
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figure 3. A section from the Vtffi of « mouse challenged with 100 mg/kg 
GTO end sacrificed 8 hours later. Pericapillary damage and 
loss of cytoplasm density in large processes is evident. 
Uranyl acetate and lead citrate stains. Magnification 7400% 

Figure 4A, Section of the VMM from a mouse given 100 mg/kg GTG end 
sacrificed 24 hours post injection. Pericapiltary distention 
of the neuropil and definite loss of large process density is 
observed. Uranly acetate and lead citrate stains. 
Magnification 7400% 
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Figure 4B. Section of the VMM from a owuie given 100 mg/kg GÎG and 
•acrificed 24 hours pott injection. A degenerating neuron 
and dendrite# are depicted. Arrow# indicate area# of 
#ynaptic complexe# on dendritic proces#e# and the dying 




CHAPTER 10. AN ULTRASÎHUCTURAL STUDY OF GOLD THIOCLUCOSE 
LESION FORMATION IN THE VENTROMEDIAL HYPOTHALAMUS. 
II. NECROTIC GOLD THIOCLUCOSE DOSES 
Introduction 
A single intraperitoneal injection of gold thioglucose (GTC) in 
nice causes hyperphagia and eventually obesity (Brecher and Waxier, 
1949). This obesity syndrome induced by CTC has been attributed to the 
destruction of the ventromedial hypothalamus (VNH) CTC (Marshall et 
al., 1955). Little is known about the development of the CUQ lesion in 
the VMM, and the data available in the literature conflict. Liebelt and 
Perry (1967) proposed that since extrahypothalamic structure* appeared 
damaged by CTC, the destruction was non-specific. Caffyn (1971t 1972 a 
and b) reported that CTC lesion formation in the Vlfll is non-specific and 
due to vascular damage (19#Z; 1983). However, Young et al. (1979) have 
noted that the median eminence, an area with a weak blood-brain barrier, 
is not vulnerable to CTC necrosis, suggesting GHXi is not a general 
vascular toxin. Debons and his colleague* (1977; 1979b) have propose^ 
that GTC is not a vascular toxin. Using subneerotie doses of GTC, 
pericapillary neural damage was observed in a small area of the VMM by 
electron microscopy. The neuropil showed signs of a breakdown in 
cellular integrity, while the capillaries appeared normal and undamaged. 
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Since earlier work by Caffyn (1971; 1972 a and b) involved the 
induction of lesions with large doses of GTC, w* have examined the 
effects of two necrotising doses of CÎG on the VHH over time, using 
electron microscopy, in an effort to characterize the onset and 
development of VNH lesions caused by large doses of GTC. Necrotizing 
doses of GTC produce discrete VMM lesions, macrolesions, easily visible 
with the light microscope. Doses of 300 and 800 mg/kg were used to 
bracket the range of drug concentration that produces a VNR macrolesion. 
Materials and Methods 
Female Cfl mice, weighing between 20-25 gm, were used in this 
study. The mice were maintained at 23^C on a 12 hour lights 12 hour dark 
photoperiod, fed Teklad Rat and Mouse Diet and given tap water freely. 
The mice were administered 300 or 800 mg/kg CTC intraperitoneally (IP) 
and sacrificed 2, 4, 6, or 12 hours after injection. The VW* from each 
mouse was prepared for ultrastructural observation as detailed in the 
preceding chapter. The cell poor region lying between the arcuate and 
VW nuclei, corresponding to the area of lesion onset and preliminary 
pericapillary damage (Debons et al., 1977; 1979b), was examined I# 
electron microscopf. 
Results 
Normal VMH Tissue 
The neuropil was tightly packed with large and small processes, 
myelinated fibers, and synaptic figures (Figure 1). Large processes 
contained numerous mitochondria, microtubules, and endoplasmic reticulum 
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profilas. Synaptic terminals, with many vesicles, formed synaptic 
complexes with the large and small processes in the area. Capillaries 
exhibited characteristic morphology. The lumen was surrounded by 
endothelial cells which, in turn, rested on a basal lamina. Adjacent to 
the capillary basal lamina were flattened cellular processes 
corresponding to astrocytic endfeet. Cell bodies were large and 
nucleated, contained mitochondria, profiles of endoplasmic reticulum and 
membranous vacuoles. 
300 ma/k* CTC 
6 hours post injection Large membrane tound, electron lucid 
spaces were adjacent to the capillary basal lamina (Figure 2). 
Scattered in the neuropil were similar electron lucid and membrane bound 
profiles. Some of these electron lucid spaces also contained owmbranow# 
vacuoles. Cell bodies were large and nucleated, with many mitochondria, 
profiles of endoplasmic reticulum, and golgi complexes. Myelinated 
fibers were normal. Capillary morphology was intact; the endothelial 
cells and basal lamina resembled those found in normal tissue. Synaptic 
profiles were wt distorted and many of these profiles were adjacent to 
electron lucid, membrane bound structures. 
12 hours post injection Pericapillary destruction was apparent 
(Figure 3). Large electron lucid, membrane bound areas were present 
adjacent to the capillary basal lamina. However, the capillary 
endothelium and basal lamina were intact and not disrupted. Cell bodies 
contained mitochondria, endoplasmic reticulum and many golgi complexes. 
Occasionally, electron lucid membranous vacuoles were seen in the cell 
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body cytoplasm. Synaptic figuras and myelinated fibers were normal. A 
generalized distention of the tMuropil was apparent; electron lucid 
areas with no membrane boundries, indicative of tissue edema« were 
scattered throughout the neuropil in areas adjacent to the capillaries. 
800 ma/k% CTC 
2 hours post injection The neuropil was densely packed with 
large and small processes, synaptic profiles, and myelinated fibers 
(Figure 4). No damage to these elements was apparent. Large processes 
contained microtubules, mitochondria and profiles of endoplasm^ic 
reticulum. On occasion, electron lucid membrmnou# vacuoles were evident 
in these large processes. Cell bodies exhibited normal morphology with 
abundant mitochondria and profiles of endoplasmic reticulum. Synaptic 
figures were not disrupted. Capillary endothelial cells and the basal 
lamina were intact. 
4 hours post injection The microvascular endothelial cells and 
basal lamina were intact (Figure 5). However, processes adjacent to the 
capillary basal lamina were electron lucid an4 contained membranous 
vacuoles. These electron lucid processes also were found in the 
neuropil not associated with a capillary. Synaptic figures were normal 
and frequently occurred adjacent to these electron lucid processes. 
Large processes contained microtubule#, mitochondria, endoplasmic 
reticulum profiles, and occasionally electron lucid membranous vacuoles. 
Cell bodies were iwrmal with mitochondria, endoplasmic reticulum and 
membranous vacuoles. Snail processes and myelinated fiN»rs exhibited no 
damage. Generally the tissue morphology was similar to the 6 hours post 
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injection 300 lag/ltg GTG tissue. 
6 hours post injection A large amount of disruption was 
observed throughout the neuropil (Figure 6). Few large processes 
appeared normal; most were electron lucid and membrane bound. 
Occaaionally membranous vacuoles were found within these electron lucid 
processes* Xn addition, extensive distention of the extracellular spaee 
was observed, and these distended areas contained membranous electron 
lucid vacuoles. Small processes, synaptic porfiles, and a few larger 
processes were not distorted. Cell bodies exhibited no damage and 
contained mitochondria, endoplasmic reticulum, and golgi complexes. 
Capillaries displayed an intact endothelial cell structure and basal 
lamina. 
12 hour# post injection A generalised destruction of the VHM 
was observed (Figure# 7A-D). Membrane bound, electron dense figures 
contained large and small, electron dense and lucid mwmbranous vacuoles 
and membrane profile* resembling endoplasmtie reticulum. Synaptic 
complexe# were formed with these electron dense figures. These synpacic 
profile# were disrupted but contained clustered synaptic vesicles. On 
occasion, tW synaptic vesicles were distended and mitochondria were 
swollen and distended. Cell bodies were no longer intact and pycnotic 
nuclei were present. A few membrane bound, electron lucid processes 
were observed. Large accumulation of membranous debris was observed in 
the area. A large amount of extracellular, electron lucid space was 
observed. Capillaries demonstrated an initial breakdown of the 
endothelium and basal lamina, as well as stasis of blood in the lumen. 
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Occasional myalinatad axons war* swollen and no normal structures, 
cellular or subcellular, could be identified. 
Discussion 
Debons and collaborators (1977; 1979b) have proposed that GTG is 
not a vascular toxin as suggested by Liebelt and Perry (1967), Caffyn 
(1971), Kochlin and Levine (1982) and Levine and Sowinski (1982% 1983), 
The macrolesion doses of GTC used in this study produced a striking 
pathology with a rapid onset. The initial phase involved loss of 
electron density of cellular processes in the pericapillary spaces, 
extending out into the neuropil. Separation of the cellular elements of 
the neuropil by large spaces, corresponding to edematous swelling, 
followed this initial phase, finally, destruction and dissolution of 
neuropil elements appeared with an accumulation of cellular debris in 
the area. 
The VMH pathology resulting from large dose C7C administration, 
resembled models of experimental brain edema (Wechaler 1967). The 
primary response was intrafiber distention in large VîW processes, 
followed later by interfiber separation. The onset of necrotic 
degeneration corresponded with the establishment of large spaces in the 
tissue as the elements of the neuropil separated. The degenerative 
phase was characterised by disrupted synapses and dissolution of the 
tissue elements of the neuropil with the accumulation of large amounts 
of cellular debris in the extracellular spaces. The small fibers of the 
neuropil were destroyed, capillaries appeared occluded, swollen, and 
150 
distorted myelinated fibers were Apparent» and mitochondria were grossly 
enlarged and occasionally disrupted. Eventually the macrolesion dose of 
GTC led to complete degeneration of the cellular components in the area 
of the lesion. 
The general response of the VMH to suhnecrotic and necrotic doses 
of GTO appeared similar. Intrafiber destruction and distention of theaa 
large processes, dendrites, resulted following the GTC injection. 
Subsequent interfiber separations in the neuropil appeared. Necrosis of 
the VMH began when degenerating, electron dense cells were observed. 
VMH necrosis was minimal and apparently temporary with microlesion dose# 
of CTC. On the other hand, macrolesion amounts of CTC caused extensive 
distention and destruction of the entire lesion area. Furthermore, the 
rate of lesion formation appeared to be directly related to CTC dose. 
It is noteworthy that none of the cerebral edema models (Wechsler 1967* 
or GTG-induced VMH necrosis produced large numbers of lysosones or 
phagocyte infiltrations for cellular digestion of debris. Only 
distention and cellular destruction were seen with extensive necrosis. 
Using a necrotic dose of GTG to produce a VMH macrolesion 
eventually caused mitochondrial destortion; the mitochondria swelled, 
became spherical in shape, and electron lucid. Subnecrotic doses of 
CTC, used to produce a VMH microlesion, did not induce noticable 
alterations in mitochondrial structure or appearance. The observed 
abnormal change in mitochondrial morphology, and possibly function, 
following a necrotic dose CTC challenge, may be related to the 
appearance of permanent hypothalamic damage, since the microlesion is 
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only temporary with normal morphology apparent within S days following 
injection with subnecrotic doses of CTC (Debons et al., 1979b}. Normal 
functional mitochondria may be required for recovery from GTG-induced 
lesions. 
Debons et al. (1979b) have shown that GTG lesion formation is 
correlated with VMH tryptophan hydroxylase activity and to a certain 
extent VMH serotonin (5KT) content. However. VMH edema must be present 
before GTG-induced necrosis will occur, regardless of the tryptophan 
hydroxylase activity or 3MT levels in the area, these investigators 
postulated that CÎC acts directly on VMH neural components, eventually 
causing massive VJffl edema due to SHÎ release. Since the hypothalamus is 
rich in 3HT (Brownstein et al,, 1976) and 3H7 is a ^ tent edema-
producing a^nt in mice (Bulle, 1957), this idea is attractive. Our 
observations are consistent with this hypothesis. Dendritic swelling 
was observed before a generalized destruction of the VMH began. This 
initiation of GTG lesion formation was probably a direct effect of GTG 
on the dendrite leading to interfiber swelling and structural damage. 
Synaptic profiles began to degenerate, possibly releasing The 5HT 
liberation may have produced abnormal capillary permeability, which 
caused additional edema and destruction, as well as microvascular 
damage. 
Edema and destruction in the VMH was much more evident and 
extensive with a necrotizing dose of (ïTC than a subnecrotic dose. In 
addition, mitochondria and myelinated fibers were damaged following 
administration of a macrolesion dose of CTC, an effect not seen in the 
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mlcrolaaion syataia. Our pramanC a&udiaa, tha pracading paper and the 
work of Debona et al. (1977; 1979 a and b) suggest that GTC is a 
substrate-specific naurotoxint vascular damage occurs secondary to 
neural destruction. 
Figure 1* A lection fron the VMI of an untreated mouce illustrating 
normal and intact neuropil and vasculature. Uranyl acetate 
and lead citrate stains. Magnification 7330x 
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Figure 2. A VHH section from e mouse treated with 300 mgAg GTG IP and 
sacrificed 6 hours after injection. Pericapillary distention 
of the neuropil is evident, Uranyl acetate and lead citrate 
stains. Magnification 7350% 
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figure 3. A tcction from the VMH of a mouse treated with 300 ingAg GTG 
IP and sacrificed 12 hours after GTG administration. 
Extensive intercellular neuropil distention is seen while the 
capillary appears undamaged. Uranyl acetate and lead citrate 
stains. Magnification 7350* 
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Figure 4. A VMM ieetion from a mouse created with 800 9%/kg CtG IP and 
aaerificed 2 hours after injection. No vascular or neural 
damge is apparent. Uranyl acetate and lead citrate stains. 
Magnification 7350* 
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figure S. A section of the VMI from a mouse treated with 800 mg/kg GTG 
IP and sacrificed 4 hours after injection. An intact 
capillary is visible with perivascular distention of the 
neuropil. Urai^l acetate and lead citrate stains. 
Magnification 7350% 

Figure 6, A VNH section from a mouse treated with 800 mg/kg GTC IP and 
sacrificed 6 hours after injection. Extensive interfiber 
distention is illustrated with undamaged capillaries. Uranyl 
acetate and lead citrate stains. Magnification 4800% 
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Figure 7A. A profile of a degenerating neuron. A aection of the VMM 
fron a moute treated with 800 mg/kg GTG IP and taerifieed 12 
hour# after GTG administration. Small arrows indicate 
diarupted or swollen snaptic figures associated with the 
neuron. The large arrow points to a swollen ndLtochondrion. 
Uranyl acetate and lead citrate stains. Magnification 16700» 
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figure 7B. Extcniive disruption of the VMM is seen from a mouse given 
800 mg/kg GTG IP and sacrificed 12 hours after injection. 
The arrow points to a deformed mitochondrion. Note the 
outline of a cell body nucleus in the upper half of the 
plate. Uranyl acetate and lead citrate stains. 
Magnification 6750% 
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figura 7C. Myelinated fiber distention from the VMM of a mouse treated 
with 800 mg/kg GIG IP end seerifieed 12 hours after 
injection. Arrows indicate swollen mitochondria. Uranyl 
acetate and lead citrate stains. Magnification 6750% 

Figurs 7D. A damaged capillary In eh« VMM of a mouie Created with 800 
mg/kg CTC XP and taerificed 12 hour# after Injection. 
Complete neuronal destruction is seen surrounding the 





The inveitigscion» reported in the preceding chapter# comprime an 
effort to understand the function of the putative satiety center in the 
ventromedial hypothalamus (VNH). One of the early theories of how the 
VMl controlled feeding behavior centered on a glucose currency. 
Proponents of the glucostatic hypothesis reasoned that this brain region 
possessed cells that monitored blood levels of glucose. As vascular 
glucose concentrations in the VHH increased to an appropriate threshold, 
satiety resulted, at least in part, by an alteration of VM* neuronal 
activity. 
Gold thioglucose (CTC) has been a useful pharmacological probe in 
the study of this VMM satiety center. It has been known for over 30 
years that a systemic CTC injection produces a focused bilateral lesion 
in the mouse VMM. This VMH lesion causes a sustained hyperphagi# and 
eventually leads to obesity. Early researchers sug^sted that GIG 
destroyed the neuronal integrity of the satiety center, thus abolishing 
the animal's ability to limit food intake. It is hypothesized that CTp 
produces hypothalamic damage by the binding of its glucose moiety to the 
VMH chemoreceptors which normally initiate satiation, however, the exact 
mechanism is not understood. 
Glucose can have a dual role in the biochemical management of body 
function by binding with functional or nutritional receptors. It is not 
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unreasonable to expect that, in tissues that possess dual receptors for 
glucose, glucose oxidation may be regulated differently from other 
tissues. We have found that glucose utilisation in the VHH is not 
dependent on insulin. Furthermore, we discovered that VMH glucose 
oxidation is affected «minimally or not at all by a variety of glucose 
analogs or by interference with the Na-K pump. A plausible explanation 
for the differences in VHH responses to these procedures from responses 
that were observed with different tissues is that the VHH glucoreceptors 
differ from those of other cells. An analogous situation is seen with 
pancreatic islets. Experimental evidence indicates that the pancreas 
possesses two classes of glucose receptors; one concerned with glucose 
metabolism and the other with horiwne secretion. Digitoxose inhibits 
the functional but not the nutritional glucoreceptors in pancreatic 
islets. However, we have observed that this sugar does not alter either 
receptor in the VHH to a great extent, since both glucose oxidation and 
the ability of GTG to induce VHH lesion formation are unaltered 
digitoxose. Digitoxose does cause a reduction of food intake during day 
tight hours, but this effect may be a perpherial phenomenon instead of a 
central one. On the other hand, alloxan, a diabetogenic inhibitor of 
glucoreceptors, depressed VHH glucose oxidation and also depressed 
feedii^ in response to a stimulus. A similar situation exists after 
phlorizin treatment. We demonstrated that phlorizin depressed VHH 
glucose oxidation and inhibited GTG-induced lesion formation in the VHH. 
These data indicate that both alloxan and phlorizin affected the 
functional as well as the nutritional glucoreceptors in the VHH. 
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Mormon** are able to modulate a variety of physiological and 
behavioral systems, and feedii% behavior is not an exception. Insulin, 
estrogen and glucocorticoids, substances that influence carbohydrate 
metabolism, can produce changes in feeding behavior and alterations of 
the VNH in response to a GTC challenge. Byperinsulinemia causes a 
hyperphagia in normal animals, presumably a consequence of the lowered 
blood glucose levels. We have shown that insulin does not influence VMM 
glucose oxidation; however, other evidence indicates that insulin has a 
direct effect on the functional VMM glucoreceptors, thereby influencing 
CTC-induced necrosis in the VHH. Mice rendered diabetic by alloxan 
treatment or anti-insulin serum are resistant to CTC lesion formation. 
Intrahypothalamic administration of insulin in these diabetic animals 
will cause a return of CTG sensitivity in the VMM. 
Estrogen is known to produce a depressive effect upon food intake, 
presumably by a direct action of the hormone on cells in the VW). In 
addition, estrogen treatment of ovariectomised mice significantly 
increases the size of GTG-induced lesions in the VW. Since estrogen 
enhances felw uptake of glucose in muscle or liver, we postulated that 
estrogen may also increase glucose oxidation in the VW, The data 
generated from this experiment are inconclusive, but estrogen clearly 
has an effect on functional vm glucoreceptors, as shown by its 
influcence on CtC lesion formation. 
Since glucocorticoids influcence carbohydrate metabolism and their 
release is indirectly controlled by hypothalamic releasing factors, it 
is tenable that this steroid may influence feeding behavior. Although 
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the administration of glucocorticoids has produced contradictory 
findings concerning food intake, rewxval of the adrenal glands reduced 
food intake. In mice made diabetic by treatment with alloxan, 
adrenalectomy ameliorates the diabetes and causes sensitization of the 
VHH to GTC. Conversely, glucocorticiod homeostasis may also change the 
responsiveness of the VMH to a GTC challenge. Mice were subjected to 
one of two types of stress, food deprivation or cold exposure. These 
conditions are kiwwn to increase systemic levels of glucocorticoids. 
Either stressor completely inhibited GTC lesion formation in the VHH. 
The elevated levels of glucocorticoids under these conditions may have 
afforded direct protection of the VMH, or may have altered VMH 
sensitivity to GTC by inducing cellular metabolic changes. 
Elucidation of the mechanism of GTC lesion formation in the VMH 
could provide an essential clue to understanding the functional 
glucoreceptors, which appear to be involved with satiation. Early 
investigators reported that CTC damage manifested itself by a breakdown 
of the VMM microcirculation. They believed that neuronal destruction 
was secondary to the ischemia induced by CTC. However, more recent 
evidence has demonstrated that neuronal degeneration is the primary 
effect of a GTC challenge. Me have confirmed the latter finding with 
ultrastructural observations of the VMH after both necrotic doses of GTC 
and doses so low that only electron microscopic evidence of degeneration 
was detectable. Therefore, it appears that CTC is a substrate-specific 
neurotoxin in the mouse VMH, albeit other brain cells possessing 
functional glucoreceptors may also be vulnerable to GTC. Moreover, we 
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determined that the first portions of the neuron affected by GTG are 
dendrites and dendritic trunks. Apparently, GTG either acts directly on 
the dendrites or produces an elevation in the concentration of some 
substance which damages the dendrites. 
Serotonin (StfT) is present in very large concentrations in the VHH. 
A current hypothesis of GTG lesion formation is that this drug causes a 
massive efflux of 5HT from terminals, thereby producing damage to 
adjacent dendrites. We reasoned that if this were the case, loading an 
animal with tryptophan should increase available 3HT in the VHH and 
thereby iiwrease the sise of GTG-induced lesions. Unexpectedly, this 
idea was not supported by our data; tryptophan pretreatment did not 
alter lesion size in mice. Only if tryptophan pretreatment was 
prolonged for several days did a GTG injection alter lesion area, and In 
this instance, the lesion size was reduced, not increased. Tryptophan 
treatment can increase 5HT stores in the brain and the 5WT turnover 
rate. However, other studies indicate that brain 5HT levels are 
unchanged following tryptophan supplementation, but that tryptophan 
i^droxylsse (an ensynw required for 5HT synthesis) activity and 5HT 
turnover are increased. If this is the case, any decrease in tryptophan 
hydroxylase activity prior to or without a change in the 5HT turnover 
rate would result in lower levels of central SBT, Such lower 5*1 levels 
in the VHH would reduce the size of a 5HT mediated GTG lesion. 
Catecholaminergic neurons are numerous in the hypothalamus. Since 
central catecholamines are involved with feeding behavior, we addressed 
the question of what effect catecholamines may have on GTG lesion 
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formation in the VMM by loading mice with tyrosine to enhance the 
synthesis of catecholamines. However, following a GTG challenge in 
these animals, no significant difference existed in lesion site between 
controls and loaded nice. Therefore, we tried the converse experiment, 
pretreatment with alpha-methylparatyrosine, a catecholamine synthesis 
inhibitor. This regimen produced significantly larger lesion following 
GTG administration, which indicates that absence of catecholamines 
sensitizes the VHh to CTC. Catecholaminergic terminals possess a SWT 
uptake mechanism, which may render depleted catecholaminergic neurons In 
the area more susceptible to 5lfr uptake. Assuming that this enhanced 
StfT influx into these catecholamine depleted neurons is toxic, when the 
area is flooded with SffT, the development of large CTC lesions would be 
expected and in agreement with our result. 
In summary, the following scheme for CTC-induced lesion formation 
is proposed. CTC concentrates in the VHH when given intraperitoneally. 
This drug, in an as yet unknown mechanism, is believed to cause release 
of 5OT from specific VMH neurons. This flood of 5HT is toxic, initially 
producing dendritic damage and edema. Subsequent neuronal breakdown and 
degeneration leads to secondary destruction of other cellular elements, 
and eventually (approximately 24 hours after a CTC injection) the entire 
VHH is obliterated. With time, the edema decreases and area scars 
appear. Alterations in insulin, glucocorticoid, estrogen or 
neurotransmitter homeostasis can change VMH responsivemess to a CTC 
challenge. Future investigative efforts should focus on clarifying the 
mechanism of CTC action in the VMH, and characterizing the glucose/CTC 
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receptor, i.e., the functional glucoreceptor. Although the VNH is 
involved with feeding behavior, the idea that this area is the exclusive 
satiety center is now questioned. A neurocircuitry system may be a more 
appropriate concept. If a direct link could be established between 
feeding and GTC neuronal damage, the role of a VfM satiety center as an 





CHAPTER 1. INHIBITION OF GOLD THIOGLUCOSE LESIONS BY 
XNTRAHYPOTHALAMXC SALINE INJECTIONS 
Introduction 
Stereotaxic placement of chemÈcalm into the brain ha# been widely 
employed in the past. This technique i# extremely uteful in a##e##ing 
the effect# of brain implant# on the central nervou# system (CNS) and 
bodily function# (Singh and Avery, 1973). One area of investigation 
that ha# utilized the stereotaxic implantation technique is the study of 
CNS control of food intake. 
Cold thioglucose (CTC), when injected in mice intraperitoneally 
(IP), will cause necrosis and subsequent lesions in the ventromedial 
hypothalamus (VNtt), producing hyperphagia and eventual obesity (Breeher 
and Waxier, 1949; Debon# et al., 1977). It ha# been demonstrated in 
mice, that a unilateral intrahypothalamic (IB) injection of phlorizin, a 
glucose transport inhibitor, into the vm at the level of the median 
eminence abolished the GTG-induced VMM necrosis, on the same side of the 
brain receiving the injection (Debon# et al., 1974a). IB saline 
injections, used as controls, had no effect on the CTG-induced 
pathology. 
The contention that the extent of CTG-induced necrosis in the VMH 
could be used as a measure of VMH glucose metabolism has been 
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9uce«9sfully employed (Young et al.. 1979). Utilizing this technique, 
we tried to determine whether or not ouabain, a Na-K pump ATPase 
inhibitor, injected IH into the VMM had any effect on CTG necrosis in 
the area. The ouabain experiments were inconclusive, however, the 
control saline infusions produced unexpected results. Specifically, the 
saline control experiments appeared to inhibit GTG lesion formation. 
Materials and Methods 
Cn female mice, weighing 20-24 gm, were maintained at 23°C on 
Teklad Rat and Mouse Diet and tap water, with a 12 hour light;12 hour 
dark photoperiod. The procedure for stereotaxic infusions into the VHH 
of nice has been previously described (Oebons et al., 1970). Ether wa# 
used as the anesthetic. Isotonic saline was infused (2 ul total volume) 
unilaterally with a Hamilton microliter syringe into the VMM at the 
level of the median eminence. Following the surgery, the mice were 
injected IP with 800 mg/kg CÏC and sacrificed 24 hours later. The 
brains were removed from the skull, fixed in Bouin's fluid, embedded in 
paraffin, sectioned at 7 um, stained with hematoxylin and eosin, and the 
VMH examined light microscopy. Lesions were examined in mice 
receiving saline infusions ami CTG and mice receiving only GTC. The 
cross sectional area of the lesion at its largest point was measured 
(Youn^ et al., 1979) using a pXanimeter and overhead slide projector at 
a magnification of 46 times. The paired t-test was used to determine 
significant differences in GTG lesion size between saline infused and 
untreated mice challenged with GTG. 
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Résulta 
In all instances, with proper placement of the chemical, saline IH 
infusions caused a partial or complete inhibition of GTC necrosis in the 
VHM (Figure 1>. This result suggests an altered VHH glucose transport 
and metabolism (Young et al., 1979). Of the seven animals used, three 
demonstrated a partial inhibition of (^G-induced necrosis, while four 
exhibited complete inhibition of GTC-induced pathology on the side of 
the brain receiving the intracranial infusion. 
The CTG lesions were generally confined to the VMM and arcuate 
nuclei. The cross sectional area of the lesions in saline infused and 
untreated mice given CTC was measured at its largest point (Young et 
al., 1979) (see Table I). The GTC lesion area in saline infused m^ice 
was significantly smaller than the lesion area in non-infused mice 
(p<O.CK>l). These data indicate that saline infusions can inhibit (#TG 
necrosis and subsequent lesion formation. 
Discussion 
These results are in contrast to illustrations of IH saline 
injections published earlier (Debons et al., 1974a). These 
photonicrographs show no apparent inhibition of the GTG lesion by 
saline. However, it is noteworthy that, in the animals receiving IH 
saline (depicted in Debons et al., 1974a), measurements of the lesioned 
area, on either side of the third ventricle, indicated that the side 
receiving the saline infusion had a smaller lesion than its untreated, 
contralateral counterpart. 
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Them* conflicting data question the technique of stereotaxic IK 
infusions into the brain. Perhaps glucose transport and metabolism is 
readily altered by an acute intracranial disturbance. The inhibition of 
GTC-induced lesions in the VNH by IN saline injections make this idea 
plausible. It is not entirely clear what aspect of the IH infusion is 
causing the inhibition of GtG necrosis. The saline infusion itself, the 
actual mechanical insertion of the syringe needle, or the pressure of 
injection are all possible mechanisms by which inhibition could be 
produced. 
Much excellent work has been done with stereotaxic implantation ami 
manipulation (Singh and Avery* 1975), thus the technique should not be 
abandoned. However, experimental design utilizing stereotaxic IH 
infusions should be scrutinized and the results interpreted with 
caution. 
Figure 1. Croti tecCioM of the moufe brain chowing the at the 
level of the median eminence, 24 hour# after various 
injections. A. A mouse given GTG IP. Characteristic 
lesions appear on either side of the third ventricle in the 
VMM. B. A mouse given an 1H infusion of saline on the right 
side of the brain (arrow indicates needle track) with 
subsequent injection of GTC IP. The right side shows partial 
inhibition of the GTG necrosis, while the left side has a 
full size lesion comparable to Figure lA. C. A mouse given 
an 18 of saline on the right side of the brain (arrow 
indicates needle track) with a subsequent injection of (TfG 
%P. The ri^t side shows complete inhibition of the GÏC 
necrosis, while the left side has a full size lesion 
cmsparable to Figure lA. (%42) 
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TABLE I. Cross sacfcional areas of GTC lesions 
Treatment n Cross sectional area of lesion 
(cm** %46)(mean SEN) 
Saline Infusion + CtC 7 1.40 0.71* 
CTC only 7 7.86 • 1.55 
* Significantly different from non-infused mice challenged with 
CTC, p<0.00l. 
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CHAPTER 2. RESISTANCE OF THE CERBIL HYPOTHALAMUS 
TO GOLD THIOGLUCOSE LESION FORMATION 
Introduction 
Breeher and Wawler (1949) discovared that a mingl* intraperitoneal 
(IP) injection of gold thioglucoee ((*TC) would cause hyperphagla and 
subsequent obesity in mice. Histological examination of the brain 
revealed that the ventromedial hypothalamus (VNH) was destroyed by GTG 
(Marshall et al., 1955; Mayer and Marshall, 1956). This CRC-induced 
bilateral lesion of the VMH is easily visible with the naked eye at the 
level of the median eminence. Two-deo%y-D-glucose (2DC) (Likuski et 
al., 1967) and phlorizin (Brown and Viles, 1982t Debons et al., 1974a) 
inhibitors of glucose utilization, prevent GTG lesion formation in the 
V# of mice. Furthermore, insulin deficiency (Debons et al., 1968; 
1969; 1970) and elevated systemic glucocorticoid levels (Debons et al., 
1979b) abolish (TTC necrosis in the VMM. This evidence suggested that 
G7G vulnerability could be used as an indicator of VMH glucose 
metabolism (Blaustein et al., 1976; Likuski et al., 1967; Young et al., 
1979). 
Much controversy has appeared in the literature concern!the 
specificity of GTG-induced lesion formation. Soa% experimental evidence 
has suggested that GTG affects brain areas that possess a weakness in 
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eh« blood-brain barrier (Caffym, 1971i Liebelc and Perry, 1967). 
However* uaii% subnecrotie dome# of CTC* Debona and co-workers (1979b) 
denonttraced by electron microacopy that CTG attacked neuronal 
componenta prior to any vascular damage. Collapse of the capillary 
endothelium was secondary. In addition, this initial GTC destruction of 
neuropil was confined to a small area between the Vtflt and arcuate 
nuclei. CTG appeared to exhibit an anatomic specificity for a small 
area of hypothalamic neuropil and a functional specificity for receptor# 
affected by changes in glucose metabolism (Debona et al., 1977; 1979b). 
Thus, GTG could be uaed effectively aa a pharmacological probe for 
hypothalamic function (Debona et al., 1979b). Moreover, we have 
confirmed Debons' observations (unpublished data). 
Glucoprivic stimuli (20C injections) not only eliminate (TFG 
necrosis, they also cause hyperphagia (Likuski et al., 1967). This 
hyperphagic response has been found in mice (Likuski et al., 1967), rat* 
(Smith and Epstein, 1969), goats (Houpt, 1974), sheep (Boupt, 1974), 
rabbits (Boupt and Banco, 1971), dogs (Russek, 1971), cats (Rowland, 
I9@l), monkey» (Smith and Epstein, 1969), and humon» (Laslo et al., 
1961). Bambsters and gerbils, however, do not respond to 20C 
administration with hyperphagia (Ritter and Balch, 1978; Rowland, 1978); 
even a preferred sunflower seed diet is not overeaten by hamsters 
administered 20C (Sclafani and Eisenstadt, 1980). 
This lack of hyperphagia, seen in gerbils and hamsters, due to 2BG 
injections suggested that a reputed area for satiety, the VMH, may be 
different functionally and/or structurally compared with other mammals. 
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Using GTG as a probe, we investigated this possibility in gerbils. In 
addition, manipulations of systemic insulin and glucocorticoid 
concentrations were done by injection and adrenalectomy (AOXI 
respectively, to enhance any necrosis produced by CtG in the gerbil VMM. 
Materials and Methods 
female Mongolian gerbils (Meriones unguiculatus). weighing 45-64 gm 
were used in this study. They were given Teklad Rat and Mouse Diet with 
sunflower seed and tap water or 0.9% saline if bilaterally AD%, A 
temperature of 23°C and a 12 hour light:12 hour dark photoperiod were 
maintained in the animal care facility. 
Six experimental groups were established. The first group, control 
gerbils, received a water injection IP <n»5). Group 2 (n*lO). group 3 
(n»4), and group 4 (n»4) received 800, 1600 and 3600 mg/kg GTG IP 
respectively. The fifth group received insulin (5 units lletin XI, IP,) 
90 minutes prior to CTG (n»12). Blood glucose was assayed by the 
glucose oxidase method. The sixth group was AOX, under ether 
anesthesia, and injected with GTG 3 days after the surgery (n»8>. 
Gerbils were decapitated 24 or 48 hours after the &TC injection. The 
brains were removed from the skull, fixed in Bouin's fluid, embedded in 
paraffin, sectioned at 7 um, stained with hematoxylin and eosin, and the 
VHH examined by light microscopy. Blood glucose statistical differences 
were determined using the t-test. 
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Rcsules 
Figure 1 depicts the VMH from a control gerbil injected with water 
24 hours before decapitation. No damage of the neuropil could be 
discerned. Gerbils challenged with GTG at the extraordinarily large 
dose of 3600 mg/kg showed no evidence of VMH necrosis or lesions (Figure 
2). Furthermoret no gerbils injected with GTG alone» at any dose 
mentioned above, developed necrosis of the VMH. The controls (Figure I) 
were indistinguishable from the gerbils injected with the high GTG dose 
(Figure 2). Animals sacrificed 48 hours after GTG administration 
produced identical results. 
Since alloxan diabetes is known to desensitize the VHH to CTC 
challenges in mice (Debons et al,, 196#; 1969; 1970) insulin was 
administered to gerbils to enhance any possible GTG response in the VMH. 
These gerbils did not show any signs of necrosis or lesion formation in 
the VHH (Figure 3). The insulin was biologically active; blood glucose 
levels were drastically reduced, p<0.(K>l (Table 1). 
An IP injection of hydrocortisone renders the mouse VMH insensitive 
to (W; necrosis (Debons et al., 1979b). Since gerbils may develop 
spontaneous hyperadrenocorticism (Vincent et al., 1979), AOX were done 
to eliminate systemic glucocorticoids. AOX gerbils challenged with GTG 
showed no sign of VHH pathology (Figure 4). 
For comparison, a cross section of the VHH from o mouse challenged 
with GTG (500 i%/kg) is depicted in Figure S. 
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Discussion 
Our results clcsrly indicate that the gerbil VHH reacts differently 
from the mouse VHH to GTC. CTC administration, in a dose 12 times that 
necessary to produce necrosis in mice, does not damige the gerbil VHH. 
In addition, hormonal manipulations that normally would sensitize th* 
mouse VHH to CIG have no effect in the gerbil. 
The mouse and gerbil also differ in their response to another 
glucose analog, 2DC. 2DC administration stimulates feeding in the mouse 
(Likuski et al., 1967), but has no effect in the gerbil (Rowland, 1978) 
Interestingly, glucoprivic stimili from 20C (LIkuski et al., 1967) or )-
thioglucose (STGHBrown, 1983) injections block CTC necrosis in the 
mouse VHH. These data imply that the mouse VHH neurons sensitive to GTC 
may be the same population of neurons sensitive to glucoprivation. 
Indeed, the idea of a GTC-lesioned glucostat system in mice has been 
postulated (Lul^ et al,, 1981t Harraszi and Holliday, 1981), However, 
Ritter et al. (1981) have demonstrated convincingly in rats that the 
glucoreceptors modulating glucoprivic feeding in response to 5TC are 
located in the hindbrain. As Ritter et al. (1981) have pointed out, 
this finding does not disprove the existence of hy^thalamic 
glucoreceptors. The facts that (»TG causes lesions in the VHH and 2DC 
and 5'fC interfere with CTC lesion formation, support the idea that the 
mouse hypothalamus possesses a population of glucoreceptive neurons. 
Although there is no evidence that glucoreceptive cells are present in 
the gerbil hypothalamus, if we assume they exist, the absence of any 
response in the gerbil VHH to a massive CTG challenge implies that 
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gorbil hypothalamic glucoraceptors differ substantially from mouse 
hypothalamic glucoreceptors. 
An explanation for the gerbil's lack of response to CTC or 20G 
administration may lie in their biological history. The gerbil may have 
had significant changes occur in central feeding control mechanisms over 
evolutionary time. Since this animal is adapted to a desert 
environmnt, potential food sources may be limited, making continual 
feeding advantageous. Feedback loops to brain regions from peripheral 
receptors involved with controlling food intake or central areas 
mediating satiety may have been altered by natural selection, accounting 
for gerbil insenaitivity to CTG lesion formation and 2DC-induced 
hyperphagia. These ideas are consistent with those proposed by Brown 
and Farrar (1980) for frogs. They found that frogs also are resistant 
to (TTC necrosis in the VMH and speculated that, (I) frogs lack a 
substrate-specific modulation of feeding behavior, or (2) changes have 
occurred in hypothalamic food intake control mechanisms through time. 
Figure I. A cross section of the VNH from a gerbil at the level of the 
median eminence, given water and decapitated 24 hours later. 
No hypothalamic damage is observable. The bar represents O.l 
MB (105%) 
Figure 2 ,  A cross section of the VMS from a gerbil at the median 
eminence level, challenged with CTG (3600 mg/kg) and 
sacrificed 24 hours after the injection. No abnormalities 
are discernible in the vm. The bar represents 0.1 mm (105%) 
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Figura 3. A crois scction from eh« VNH of a garbil at the level of the 
median eminence, treated with insulin and GTC (800 mg/kg) and 
sacrificed 24 hours after the GTC injection. No necrosis or 
lesion in the area is apparent. The bar represents O.l mm 
(105x) 
figure 4. A cross section of the VKB at the median eminence level, from 
an AD% gerbil challenged with GTC (800 mg/kg) and sacrificed 
24 hours later. No damage to the VNH is seen. The bar 
represents O.l mm (105%) 
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Figure S. k cross section of the Vlffi at the level of the median 
eminence from a mouse challenged with 500 mg/kg GTG and 
sacrificed 24 Iwwrs later. The typical bilateral CTC-induced 
VHH lesion is seen an either side of the third ventricle. 
The bar represents 0.1 mm (lOSx) 
19 J 
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TABLE %. Blood sugar levels in gerbils given insulin and GTC 
Condition n ng S glucose 
(flwan * SEH) 
Before insulin injection 12 149.0 11.2 
90 minutes after insulin adminis­ 11 54.8 6.9* 
tration and before GTC injection 
24 hours after GTC administration 4 45.5 11.1 
* Significantly different from the other two conditions, piO.OOl. 
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CHAPTER 3. ABSENCE OF LESIONS IN THE HYPOTHALAMUS OF 
FROGS TREATED WITH COLD THXOGLUCOSE 
Introduction 
Gold thioglucofo (GIG) ha# been known for almomt three decades to 
cauae obeaity. It lelectively deatroya neurona in the brain and thua 
haa become a pharmacological tool Cor atuding central nervoua control of 
food intake in maasala. 
Brecher and Waxier (1949) were the firat to ahow that a single 
intraperitoneal injection of CTC will cause hyperphagia and eventual 
obesity in mice. Histological studiea have denonatrated that CTC 
selectively destroys neuronal cells in the ventromedial hypothalamua 
(VNH) (Marshall et al.» 1955), This area of the brain seems to be 
responsible for controlling food intake and haa been called the satiety 
center. Aa further aubatantiation of the involvement of the VMS in 
satiety* electrolytic deatruction (Hetherington and Ranson. 1940), 
cauterization (Stevenaon, 1969) and knife cut# (Albert and Storlien, 
1969) in thia area can lead to hyperphagia and obesity. 
The frog, Rana pipiena, has been used extenaively in physiological 
investigation* but very little is known about the control of food intake 
in this species or in other lower vertebrates. We therefore chose to 
investigate whether or not a CTC sensitive satiety center exists in Rana 
pipiena. 
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Naesfials and Methods 
Adult Rana pipiana weighing 20-30 gm were obtained from Turtox 
Biological Supply. The animal# were housed in moist aquaria at 23*C 
under a 12 hour light:12 hour dark routine. Frogs were force-fed liver 
when not in use, but were fasted 3-5 days before experimentation. 
Animals were acctimatixed to laboratory conditions for at least 2 weeks 
before use. Experiments were conducted in late October. 
Six frogs were injected intraperitoneally with a single dose of 800 
or 1000 mg/kg aqueous CTC. Six control frogs were injected with a 
aimilar volume of saline. AniMls were killed after 4# hours and their 
brain# were fixed in Bouin's solution for 48 hours. The brains were 
embedded in paraffin and the entire diencephalon serially section at 7 
um. Sections were stained with hematoxylin and eosin aiW surveyed by 
light microscopy for pathological changes that might have been induced 
by CTC. 
Results 
CTG failed to cause either necrosis or lesions in the frog 
hypothalamws. All brain section# appeared normal and CTC-treated brains 
were indietinguishable from those of the controls. 
Discussion 
The absence of lesions after GTG treatment of these frogs suggests 
that the hypothalamus is either less responsive to CTC than that of mice 
and rats, in which this dose is considered to be pharmacological (Debons 
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et al., 1977), or is not rasponsiv» at all. Either alternative 
indicates considerable change in hypothalamic control of food intake 
through evolutionary tim and suggests some possibilities concerning 
satiety in this species. 
First, frogs may not possess a satiety center for controlling food 
intake. Perhaps they have only a single center, ^re analogous to the 
mammalian hunger or feeding center, in the lateral hypothalamus. In 
this case feeding could take place continually when food is available 
and perhaps only stop when peripheral receptors, such as stretch 
receptors in the gut or chemoreceptors in the liver, inhibit feeding by 
nervous input to the feeding center. Peripheral input to the 
hypothalamic centers from receptors such as hepatic satiety receptors is 
being investigated in mammal# (Russek, 1970; 1971). 
Second, frogs might have a satiety center that is seasonally 
functional, being active only in warmer months when food is most 
available. Frogs seasonally store lipids and carbohydrates (Farrar, 
1972; Mizell, 1965), but the possible role of hyperphagia in this 
storage has not been invesitgated. 
Lastly, it is possible that Rana pipiens has a satiety center 
insensitive to CIC. Likuski et al. (1967) have shown that the glucose 
moiety of GIG is necessary for VHM necrosis in mice. Bowever, it is not 
clear to what extent amphibian metabolism is based on a glucose currency 
(Copeland and deRoos, 1979), and thus to what extent food intake control 
would be based on changes in glucose concentration. Adult frogs 
primarily eat insects, which are generally not high in carbohydrates. 
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Blood glucose levels are characteristically lower in amphibians than in 
other vertebrates at comparable temperature and metabolic rate 
(Umminger* 1977). If there is an amphibian satiety center it could be 
more sensitive to fatty acids or amino acids than to glucose. Further 
investigation of food intake control in amphibians and other lower 
vertebrates is desirable. 
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